Retinal ischemia: Mechanisms of damage and potential therapeutic strategies

Progress in Retinal and Eye Research

Volumn 23, Issue 1, 2004, Pages 91-147

  Osborne, Neville N ^a   Casson, Robert J ^a   Wood, John P M ^a   Chidlow, Glyn ^a   Graham, Mark ^a   Melena, José ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMINOGUANIDINE; AMPA RECEPTOR ANTAGONIST; ANTIOXIDANT; APOPTOSIS INHIBITOR; ASCORBIC ACID 2 OCTADECYL ETHER; BASIC FIBROBLAST GROWTH FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CALCIUM CHANNEL BLOCKING AGENT; CARNITINE; CILIARY NEUROTROPHIC FACTOR; CYCLOOXYGENASE 2 INHIBITOR; DIZOCILPINE; ERYTHROPOIETIN; GINKGO BILOBA EXTRACT; HEAT SHOCK PROTEIN 27; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; KAINIC ACID RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N(G) NITROARGININE METHYL ESTER; NIPRADILOL; PENTOXIFYLLINE; PIGMENT EPITHELIUM DERIVED FACTOR; POTASSIUM CHANNEL STIMULATING AGENT; SC 51; SEROTONIN 1A AGONIST; SEROTONIN 2 ANTAGONIST; SODIUM CHANNEL BLOCKING AGENT; TRIMETAZIDINE; UNINDEXED DRUG;

ACIDOSIS; ANGIOGENESIS; ATTENUATION; BLINDNESS; CALCIUM TRANSPORT; CELL METABOLISM; CLINICAL TRIAL; DEPOLARIZATION; DIABETIC RETINOPATHY; DISEASE RESISTANCE; DROWSINESS; DRUG CLEARANCE; DRUG MEGADOSE; ELECTRORETINOGRAM; ENERGY; EXPERIMENTAL ANIMAL; EYE TOXICITY; HOMEOSTASIS; HUMAN; METABOLISM; MOTOR DYSFUNCTION; NAUSEA; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PHOTORECEPTOR; PRIORITY JOURNAL; RETINA AMACRINE CELL; RETINA BLOOD VESSEL; RETINA INJURY; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION; REVIEW; SODIUM TRANSPORT; STIMULATION; STROKE; VISUAL IMPAIRMENT;

EID: 0842282082     PISSN: 13509462     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2003.12.001     Document Type: Review

References (592)

1. Abdel-Hamid K.M., Tymianski M. Mechanisms and effects of intracellular calcium buffering on neuronal survival in organotypic hippocampal cultures exposed to anoxia/aglycemia or to excitotoxins. J. Neurosci. 17:1997;3538-3553.
2. Abe K., Aoki M., Kawagoe J., Yoshida T., Hattori A., Kogure K., Itoyama Y. Ischemic delayed neuronal death. A mitochondrial hypothesis. Stroke. 26:1995;1478-1489.
3. Abu El-Asrar A.M., Desmet S., Meersschaert A., Dralands L., Missotten L., Geboes K. Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus. Am. J. Ophthalmol. 132:2001;551-556.
4. Adachi K., Fujita Y., Morizane C., Akaike A., Ueda M., Satoh M., Masai H., Kashii S., Honda Y. Inhibition of NMDA receptors and nitric oxide synthase reduces ischemic injury of the retina. Eur. J. Pharmacol. 350:1998;53-57.
5. Agarwal N., Martin E., Krishnamoorthy R.R., Landers R., Wen R., Krueger S., Kapin M.A., Collier R.J. Levobetaxolol-induced up-regulation of retinal bFGF and CNTF mRNAS and preservation of retinal function against a photic-induced retinopathy. Exp. Eye Res. 74:2002;445-453.
6. Akiyama H., Nakazawa T., Shimura M., Tomita H., Tamai M. Presence of mitogen-activated protein kinase in retinal Muller cells and its neuroprotective effect ischemia-reperfusion injury. Neuroreport. 13:2002;2103-2107.
7. Alagoz G., Celiker U., Ilhan N., Yekeler H., Demir T., Celiker H. L-carnitine in experimental retinal ischemia-reperfusion injury. Ophthalmologica. 216:2002;144-150.
8. Albers G.W., Saenz R.E., Moses J.-A.J., Choi D.W. Safety and tolerance of oral dextromethorphan in patients at risk for brain ischemia. Stroke. 22:1991;1075-1077.
9. Albers G.W., Saenz R.E., Moses J.-A.J. Tolerability of oral dextromethorphan in patients with a history of brain ischemia. Clin. Neuropharmacol. 15:1992;509-514.
10. Alvarez-Maubecin V., Garcia-Hernandez F., Williams J.T., Van Bockstaele E.J. Functional coupling between neurons and glia. J. Neurosci. 20:2000;4091-4098.
11. Ames A., Wright R.L., Kowada M., Thurston J.M., Majno G. Cerebral ischemia. II. The no-reflow phenomenon. Am. J. Pathol. 52:1968;437-453.
12. + transport J. Neurosci. 12:1992;840-853.
13. 2+-permeable AMPA receptor promotes delayed cell death of hippocampal CA1 neurons following transient forebrain ischemia. Neurosci. Res. 46:2003;41-51.
14. Ashton N., Harry J. The pathology of cotton wool spots and cytoid bodies in hypertensive retinopathy and other diseases. Trans. Ophthalmol. Soc. UK. 83:1963;91-114.
15. Astrup J., Siesjo B.K., Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke. 12:1981;723-725.
16. Attwell D., Barbour B., Szatkowski M. Nonvesicular release of neurotransmitter. Neuron. 11:1993;401-407.
17. Banin E., Berenshtein E., Kitrossky N., Pe'er J., Chevion M. Gallium-desferrioxamine protects the cat retina against injury after ischemia and reperfusion. Free Radical Biol. Med. 28:2000;315-323.
18. Barbour B., Brew H., Attwell D. Electrogenic glutamate uptake in glial cells is activated by intracellular potassium. Nature. 335:1988;433-435.
19. Barbour B., Brew H., Attwell D. Electrogenic uptake of glutamate and aspartate into glial cells isolated from the salamander (Ambystoma) retina. J. Physiol. 436:1991;169-193.
20. Barnett N.L., Osborne N.N. Prolonged bilateral carotid artery occlusion induces electrophysiological and immunohistochemical changes to the rat retina without causing histological damage. Exp. Eye Res. 61:1995;83-90.
21. Barnett N.L., Pow D.V., Bull N.D. Differential perturbation of neuronal and glial glutamate transport systems in retinal ischaemia. Neurochem. Int. 39:2001;291-299.
22. 2+ channels and in gerbil global cerebral ischaemia. Eur. J. Pharmacol. 299:1996;103-112.
23. Bazan N.G. Free arachidonic acid and other lipids in the nervous system during early ischemia and after electroshock. Adv. Exp. Med. Biol. 72:1976;317-335.
24. Beatty S., Au Eong K.G. Acute occlusion of the retinal arteries. current concepts and recent advances in diagnosis and management J. Accid. Emerg. Med. 17:2000;324-329.
25. Becerra S.P., Amaral J. Erythropoietin - an endogenous retinal survival factor. N. Engl. J. Med. 347:2002;1968-1970.
26. Bednar M.M., Kohut J.J., Kimelberg H.K., Gross J.J., Gross C.E. In vitro evidence supporting two mechanisms of action of the anion transport inhibitor L-644,711 in cerebral ischemia. Neurol. Res. 14:1992;53-56.
27. Beiran I., Goldenberg I., Adir Y., Tamir A., Shupak A., Miller B. Early hyperbaric oxygen therapy for retinal artery occlusion. Eur. J. Ophthalmol. 11:2001;345-350.
28. Bem J.L., Peck R. Dextromethorphan. An overview of safety issues. Drug Safe. 7:1992;190-199.
29. Ben Nun J., Alder V.A., Cringle S.J., Constable I.J. A new method for oxygen supply to acute ischemic retina. Invest. Ophthalmol. Vis. Sci. 29:1988;298-304.
30. Benveniste H., Drejer J., Schousboe A., Diemer N.H. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369-1374.
31. Berman E.R. Biochemistry of the Eye. 1991;Plenum Press, New York.
32. Bezzi P., Carmignoto G., Pasti L., Vesce S., Rossi D., Rizzini B.L., Pozzan T., Volterra A. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature. 391:1998;281-285.
33. Billups B., Attwell D. Modulation of non-vesicular glutamate release by pH. Nature. 379:1996;171-174.
34. 2+ channels in rat cultured cortical neurons. Eur. J. Pharmacol. 257:1994;297-301.
35. Blair N.P., Shaw W.E., Dunn R.J., Tsukarhara Y., Floro C., Rusin M.M. Limitation of retinal injury by vitreoperfusion initiated after onset of ischemia. Arch. Ophthalmol. 109:1991;113-118.
36. Block F., Schwarz M. Effects of antioxidants on ischemic retinal dysfunction. Exp. Eye Res. 64:1997;559-564.
37. Block F., Schwarz M. The b-wave of the electroretinogram as an index of retinal ischemia. Gen. Pharmacol. 30:1998;281-287.
38. Block F., Schwarz M., Sontag K.H. Retinal ischemia induced by occlusion of both common carotid arteries in rats as demonstrated by electroretinography. Neurosci. Lett. 144:1992;124-126.
39. Bock J., Bornschein H. Electrophysiological and histological aspects of retinal ischaemia. Trans. Ophthalmol. Soc. UK. 91:1971;399-403.
40. Boening J.A., Kass I.S., Cottrell J.E., Chambers G. The effect of blocking sodium influx on anoxic damage in the rat hippocampal slice. Neuroscience. 33:1989;263-268.
41. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S.A. Apoptosis and necrosis. two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures Proc. Natl. Acad. Sci. USA. 92:1995;7162-7166.
42. Bonne C., Muller A., Villain M. Free radicals in retinal ischemia. Gen. Pharmacol. 30:1998;275-280.
43. Bonventre J.V., Huang Z., Taheri M.R., O'Leary E., Li E., Moskowitz M.A., Sapirstein A. Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature. 390:1997;622-625.
44. Boris-Moller F., Wieloch T. Changes in the extracellular levels of glutamate and aspartate during ischemia and hypoglycemia. Effects of hypothermia. Exp. Brain Res. 121:1998;277-284.
45. Brandstatter J.H., Hartveit E., Sassoe Pognetto M., Wassle H. Expression of NMDA and high-affinity kainate receptor subunit mRNAs in the adult rat retina. Eur. J. Neurosci. 6:1994;1100-1112.
46. 2+ channels and anoxic injury in rat CNS white matter. J. Neurophysiol. 85:2001;900-911.
47. Brown G.C. Systemic associations of retinal arterial obstructive disease. Int. Ophthalmol. Clin. 31:1991;1-14.
48. Bruno V., Battaglia G., Copani A., D'Onofrio M., Di Iorio P., De Blasi A., Melchiorri D., Flor P.J., Nicoletti F. Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs. J. Cereb. Blood Flow Metab. 21:2001;1013-1033.
49. Buchi E.R., Suivaizdis I., Fu J. Pressure-induced retinal ischemia in rats. an experimental model for quantitative study Ophthalmologica. 203:1991;138-147.
50. Buchi E.R., Lam T.T., Suvaizdis I., Tso M.O. Injuries induced by diffuse photodynamic action in retina and choroid of albino rats. Morphologic study of an experimental model. Retina. 14:1994;370-378.
51. Budd S.L. Mechanisms of neuronal damage in brain hypoxia/ischemia. focus on the role of mitochondrial calcium accumulation Pharmacol. Ther. 80:1998;203-229.
52. Budihardjo I., Oliver H., Lutter M., Luo X., Wang X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15:1999;269-290.
53. Bull N.D., Barnett N.L. Antagonists of protein kinase C inhibit rat retinal glutamate transport activity in situ. J. Neurochem. 81:2002;472-480.
54. Burgos R., Simo R., Audi L., Mateo C., Mesa J., Garcia Ramirez M., Carrascosa A. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy. Diabetologia. 40:1997;1107-1109.
55. Burgos R., Mateo C., Canton A., Hernandez C., Mesa J., Simo R. Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy. a case-control study Diabetes Care. 23:2000;80-83.
56. Burke S.P., Nadler J.V. Effects of glucose deficiency on glutamate/aspartate release and excitatory synaptic responses in the hippocampal CA1 area in vitro. Brain Res. 500:1989;333-342.
57. Calzada J.I., Jones B.E., Netland P.A., Johnson D.A. Glutamate-induced excitotoxicity in retina. neuroprotection with receptor antagonist, dextromethorphan, but not with calcium channel blockers Neurochem. Res. 27:2002;79-88.
58. Cao W., Zaharia M., Drumheller A., Casanova C., Lafond G., Brunette J.R., Jolicoeur F.B. Effects of dextromethorphan on ischemia induced electroretinogram changes in rabbit. Curr. Eye Res. 13:1994;97-102.
59. Caprioli J., Kitano S., Morgan J.E. Hyperthermia and hypoxia increase tolerance of retinal ganglion cells to anoxia and excitotoxicity. Invest. Ophthalmol. Vis. Sci. 37:1996;2376-2381.
60. Casson, R.J., Chidlow, G., Wood, J.P.M., Osborne, N.N., 2004. Hyperglycemia protects against ischemic retinal injury. Arch. Ophthalmol., in press.
61. Casson R.J., Wood J.P.M., Melena J., Chidlow G., Osborne N.N. Ischemic preconditioning protects photoreceptors against light-induced injury. Invest. Ophthalmol. Vis. Sci. 44:2003;1348-1354.
62. Castellon R., Hamdi H.K., Sacerio I., Aoki A.M., Kenney M.C., Ljubimov A.V. Effects of angiogenic growth factor combinations on retinal endothelial cells. Exp. Eye Res. 74:2002;523-535.
63. Cazevieille C., Muller A., Meynier F., Bonne C. Superoxide and nitric oxide cooperation in hypoxia/reoxygenation-induced neuron injury. Free Radical Biol. Med. 14:1993;389-395.
64. Celebi S., Dilsiz N., Yilmaz T., Kukner A.S. Effects of melatonin, vitamin E and octreotide on lipid peroxidation during ischemia-reperfusion in the guinea pig retina. Eur. J. Ophthalmol. 12:2002;77-83.
65. Chan P.H. Role of oxidants in ischemic brain damage. Stroke. 27:1996;1124-1129.
66. Chao H.M., Osborne N.N. Topically applied clonidine protects the rat retina from ischaemia/reperfusion by stimulating alpha(2)-adrenoceptors and not by an action on imidazoline receptors. Brain Res. 904:2001;126-136.
67. Chao H.M., Chidlow G., Melena J., Wood J.P.M., Osborne N.N. An investigation into the potential mechanisms underlying the neuroprotective effect of clonidine in the retina. Brain Res. 877:2000;47-57.
68. Chebib M., Johnston G.A. The 'ABC' of GABA receptors. a brief review Clin. Exp. Pharmacol. Physiol. 26:1999;937-940.
69. Chebabo S.R., Do-Carmo R.J. Phenytoin and retinal spreading depression. Brain Res. 551:1991;16-19.
70. Chen C.H., Chen S.C. Evidence of the presence of a specific vascular endothelial growth factor in fetal bovine retina. Exp. Cell Res. 169:1987;287-295.
71. Chen Q., Moulder K., Tenkova T., Hardy K., Olney J.W., Romano C. Excitotoxic cell death dependent on inhibitory receptor activation. Exp. Neurol. 160:1999;215-225.
72. Chen Q.X., Perkins K.L., Choi D.W., Wong R.K. Secondary activation of a cation conductance is responsible for NMDA toxicity in acutely isolated hippocampal neurons. J. Neurosci. 17:1997;4032-4036.
73. Chen S., Diamond J.S. Synaptically released glutamate activates extrasynaptic NMDA receptors on cells in the ganglion cell layer of rat retina. J. Neurosci. 22:2002;2165-2173.
74. Cheon E.W., Park C.H., Kang S.S., Cho G.J., Yoo J.M., Song J.K., Choi W.S. Nitric oxide synthase expression in the transient ischemic rat retina. neuroprotection of betaxolol Neurosci. Lett. 330:2002;265-269.
75. Cheon E.W., Park C.H., Kang S.S., Cho G.J., Yoo J.M., Song J.K., Choi W.S. Change in endothelial nitric oxide synthase in the rat retina following transient ischemia. Neuroreport. 14:2003;329-333.
76. Cheung J.Y., Bonventre J.V., Malis C.D., Leaf A. Calcium and ischemic injury. N. Engl. J. Med. 314:1986;1670-1676.
77. Chi O.Z., Anwar M., Sinha A.K., Weiss H.R. Effects of MK-801 on cerebral regional oxygen consumption in focal cerebral ischemia in rats. Circ. Res. 69:1991;414-420.
78. Chiang S.K., Lam T.T. Post-treatment at 12 or 18 hours with 3-aminobenzamide ameliorates retinal ischemia-reperfusion damage. Invest. Ophthalmol. Vis. Sci. 41:2000;3210-3214.
79. Chidlow G., Osborne N.N. Rat retinal ganglion cell loss caused by kainate, NMDA and ischemia correlates with a reduction in mRNA and protein of Thy-1 and neurofilament light. Brain Res. 963:2003;298-306.
80. + channels. comparison with other α-adrenoceptor antagonists Br. J. Pharmacol. 130:2000;759-766.
81. Chidlow G., Schmidt K.G., Wood J.P., Melena J., Osborne N.N. Alpha-lipoic acid protects the retina against ischemia-reperfusion. Neuropharmacology. 43:2002;1015-1025.
82. Choi D.W. Ionic dependence of glutamate neurotoxicity. J. Neurosci. 7:1987;369-379.
83. Choi D.W., Maulucci Gedde M., Kriegstein A.R. Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 7:1987;357-368.
84. Christine C.W., Choi D.W. Effect of zinc on NMDA receptor-mediated channel currents in cortical neurons. J. Neurosci. 10:1990;108-116.
85. Chun M.H., Kim I.B., Ju W.K., Kim K.Y., Lee M.Y., Joo C.K., Chung J.W. Horizontal cells of the rat retina are resistant to degenerative processes induced by ischemia-reperfusion. Neurosci. Lett. 260:1999;125-128.
86. Ciardella A.P., Donsoff I.M., Guyer D.R., Adamis A., Yannuzzi L.A. Antiangiogenesis agents. Ophthalmol. Clin. North Am. 15:2002;453-458.
87. Clark G.D., Happel L.T., Zorumski C.F., Bazan N.G. Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor. Neuron. 9:1992;1211-1216.
88. Coleman P.A., Miller R.F. Do N-methyl-D-aspartate receptors mediate synaptic responses in the mudpuppy retina? J. Neurosci. 8:1988;4728-4733.
89. Collaborators T.C.V.O.S. Baseline and early natural history report. Arch. Ophthalmol. 111:1993;1087-1095.
90. Collaborators T.C.V.O.S. Natural history and clinical management of central retinal vein occlusion. Arch. Ophthalmol. 115:1997;486-491.
91. Cringle S.J., Yu D.Y., Alder V.A., Su E.N. Intravitreal perfluorocarbon and oxygen delivery in induced retinal ischaemia. Adv. Exp. Med. Biol. 361:1994;303-311.
92. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem. J. 341:1999;233-249.
93. Cross H.R. Trimetazidine for stable angina pectoris. Expert Opin. Pharmacother. 2:2001;857-875.
94. Crosson C.E., Willis J.A., Potter D.E. Effect of the calcium antagonist, nifedipine, on ischemic retinal dysfunction. J. Ocul. Pharmacol. 6:1990;293-299.
95. Cui Q., Harvey A.R. At least two mechanisms are involved in the death of retinal ganglion cells following target ablation in neonatal rats. J. Neurosci. 15:1995;8143-8155.
96. Cullen J.P., Aldrete J.A., Jankovsky L., Romo-Salas F. Protective action of phenytoin in cerebral ischemia. Anesth. Analg. 58:1979;165-169.
97. Cummings B.S., McHowat J., Schnellmann R.G. Phospholipase A(2)s in cell injury and death. J. Pharmacol. Exp. Ther. 294:2000;793-799.
98. Cuzzocrea S., Riley D.P., Caputi A.P., Salvemini D. Antioxidant therapy. a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury Pharmacol. Rev. 53:2001;135-159.
99. Danton G.H., Dietrich W.D. Inflammatory mechanisms after ischemia and stroke. J. Neuropathol. Exp. Neurol. 62:2003;127-136.
100. Dao D.N., Ahdab-Barmada M., Schor N.F. Cerebellar glutamine synthetase in children after hypoxia or ischemia. Stroke. 22:1991;1312-1316.
101. Daugeliene L., Niwa M., Hara A., Matsuno H., Yamamoto T., Kitazawa Y., Uematsu T. Transient ischemic injury in the rat retina caused by thrombotic occlusion-thrombolytic reperfusion. Invest. Ophthalmol. Vis. Sci. 41:2000;2743-2747.
102. Davalos A., Castillo J., Serena J., Noya M. Duration of glutamate release after acute ischemic stroke. Stroke. 28:1997;708-710.
103. David P., Lusky M., Teichberg V.I. Involvement of excitatory neurotransmitters in the damage produced in chick embryo retinas by anoxia and extracellular high potassium. Exp. Eye Res. 46:1988;657-662.
104. Davidson C.M., Pappas B.A., Stevens W.D., Fortin T., Bennett S.A. Chronic cerebral hypoperfusion. loss of pupillary reflex, visual impairment and retinal neurodegeneration Brain Res. 859:2000;96-103.
105. 2+-mobilizing activity of cyclic ADP-ribose. Cell Biochem. Biophys. 28:1998;45-62.
106. De Keyser J., Sulter G., Luiten P.G. Clinical trials with neuroprotective drugs in acute ischaemic stroke. are we doing the right thing? Trends Neurosci. 22:1999;535-540.
107. Degi R., Thore C., Bari F., Thrikawala N., Nogradi A., Robins G., Domoki F., Beasley T.C., Busija D.W. Ischemia increases prostaglandin H synthase-2 levels in retina and visual cortex in piglets. Graefes Arch. Clin. Exp. Ophthalmol. 239:2001;59-65.
108. Demir T., Ulas F., Ozercan I., Ilhan N., Celiker U., Yasar M.A. Protective effects of pentoxifylline in retinal ischemia/reperfusion injury. Ophthalmologica. 217:2003;337-341.
109. Destro M., Gragoudas E.S. Arterial occlusions. Albert D .M., Jakobiec F .A. Principles and Practice of Ophthalmology. 2000;1879-1884 W.B. Saunders, Philadelphia.
110. Dib M. Amyotrophic lateral sclerosis. progress and prospects for treatment Drugs. 63:2003;289-310.
111. Dick E., Miller R.F. Light-evoked potassium activity in mudpuppy retina. its relationship to the b-wave of the electroretinogram Brain Res. 154:1978;388-394.
112. Doly M., Braquet P., Bonhomme B., Meyniel G. Effects of lipid peroxidation on the isolated rat retina. Ophthalmic Res. 16:1984;292-296.
113. Donello J.E., Padillo E.U., Webster M.L., Wheeler L.A., Gil D.W. alpha(2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia. J. Pharmacol. Exp. Ther. 296:2001;216-223.
114. A receptor subtypes by Zn2+. Neuron. 5:1990;781-788.
115. Drejer J., Benveniste H., Diemer N.H., Schousboe A. Cellular origin of ischemia-induced glutamate release from brain tissue in vivo and in vitro. J. Neurochem. 45:1985;145-151.
116. Dreyer E.B., Pan Z.H., Storm S., Lipton S.A. Greater sensitivity of larger retinal ganglion cells to NMDA-mediated cell death. Neuroreport. 5:1994;629-631.
117. Droy-Lefaix M.T., Cluzel J., Menerath J.M., Bonhomme B., Doly M. Antioxidant effect of a Ginkgo biloba extract (EGb 761) on the retina. Int. J. Tissue React. 17:1995;93-100.
118. Drummond J.C., Piyash P.M., Kimbro J.R. Neuroprotection failure in stroke. Lancet. 356:2000;1032-1033.
119. Duarte C.B., Ferreira I.L., Santos P.F., Carvalho A.L., Agostinho P.M., Carvalho A.P. Glutamate in life and death of retinal amacrine cells. Gen. Pharmacol. 30:1998;289-295.
120. Duffy S., MacVicar B.A. In vitro ischemia promotes calcium influx and intracellular calcium release in hippocampal astrocytes. J. Neurosci. 16:1996;71-81.
121. Duke-Elder, S., Dobree, J.H., 1967. System of Ophthalmology, Vol. X. Diseases of the Retina. CV Mosby, St Louis.
122. 2+ and the potentiation by serum albumin Brain Res. 560:1991;282-290.
123. el Asrar A.M., Morse P.H., Maimone D., Torczynski E., Reder A.T. MK-801 protects retinal neurons from hypoxia and the toxicity of glutamate and aspartate. Invest. Ophthalmol. Vis. Sci. 33:1992;3463-3468.
124. Ernest, J.T., 1994. Retinal circulation. In: Ogden, T. E. (Eds.), Basic Science and Inherited Retinal Disease, Vol. 2. Mosby, St. Louis, pp. 72-75.
125. Ettaiche M., Fillacier K., Widmann C., Heurteaux C., Lazdunski M. Riluzole improves functional recovery after ischemia in the rat retina. Invest. Ophthalmol. Vis. Sci. 40:1999;729-736.
126. ATP) in retina. a key role for delayed ischemic tolerance Brain Res. 890:2001;118-129.
127. Faberowski N., Stefansson E., Davidson R.C. Local hypothermia protects the retina from ischemia. A quantitative study in the rat. Invest. Ophthalmol. Vis. Sci. 30:1989;2309-2313.
128. Farooqui A.A., Yi O.W., Lu X.R., Halliwell B., Horrocks L.A. Neurochemical consequences of kainate-induced toxicity in brain. involvement of arachidonic acid release and prevention of toxicity by phospholipase A2 inhibitors Brain Res. Brain Res. Rev. 38:2001;61-78.
129. Feher J., Antal M. Ischemic retinal alterations in cardiac arrest. Ann. Ophthalmol. 11:1979;909-913.
130. Fern R. Intracellular calcium and cell death during ischemia in neonatal rat white matter astrocytes in situ. J. Neurosci. 18:1998;7232-7243.
131. 2+ influx through glutamate receptor-associated channels in retina cells correlates with neuronal cell death. Eur. J. Pharmacol. 302:1996;153-162.
132. Ferreira I.L., Duarte C.B., Carvalho A.P. 'Chemical ischemia' in cultured retina cells. the role of excitatory amino acid receptors and of energy levels on cell death Brain Res. 768:1997;157-166.
133. Ferrer I., Planas A.M. Signaling of cell death and cell survival following focal cerebral ischemia. life and death struggle in the penumbra J. Neuropathol. Exp. Neurol. 62:2003;329-339.
134. Fischer E.G., Ames A.r., Hedley Whyte E.T., O'Gorman S. Reassessment of cerebral capillary changes in acute global ischemia and their relationship to the "no-reflow phenomenon" Stroke. 8:1977;36-39.
135. Flammer J., Orgul S. Optic nerve blood-flow abnormalities in glaucoma. Prog. Retin. Eye Res. 17:1998;267-289.
136. Fletcher E.L., Kalloniatis M. Localisation of amino acid neurotransmitters during postnatal development of the rat retina. J. Comp. Neurol. 380:1997;449-471.
137. Fletcher E.L., Hack I., Brandstatter J.H., Wassle H. Synaptic localization of NMDA receptor subunits in the rat retina. J. Comp. Neurol. 420:2000;98-112.
138. Flor P.J., Battaglia G., Nicoletti F., Gasparini F., Bruno V. Neuroprotective activity of metabotropic glutamate receptor ligands. Adv. Exp. Med. Biol. 513:2002;197-223.
139. Fontaine V., Mohand-Said S., Hanoteau N., Fuchs C., Pfizenmaier K., Eisel U. Neurodegenerative and neuroprotective effects of tumor necrosis factor (TNF) in retinal ischemia. opposite roles of TNF receptor 1 and TNF receptor 2 J. Neurosci. 22:2002;RC216.
140. Fontana A.C., Guizzo R., Beleboni R.A.M., Coimbra N.C., Amara S.G., Santos W.F., Coutinho-Netto J. Purification of a neuroprotective component of Parawixia bistriata spider venom that enhances glutamate uptake. Br. J. Pharmacol. 139:2003;1297-1309.
141. Foulds W.S., Johnson N.F. Rabbit electroretinogram during recovery from induced ischaemia. Trans. Ophthalmol. Soc. UK. 94:1974;383-393.
142. Fragoso G., Lopez Colome A.M. Excitatory amino acid-induced inositol phosphate formation in cultured retinal pigment epithelium. Vis. Neurosci. 16:1999;263-269.
143. Franklin J.L., Johnson E.M. Jr. Suppression of programmed neuronal death by sustained elevation of cytoplasmic calcium. Trends Neurosci. 15:1992;501-508.
144. Frantseva M.V., Carlen P.L., Perez-Velazquez J.L. Dynamics of intracellular calcium and free radical production during ischemia in pyramidal neurons. Free Radical Biol. Med. 31:2001;1216-1227.
145. Frederickson C.J., Bush A.I. Synaptically released zinc. physiological functions and pathological effects Biometals. 14:2001;353-366.
146. Fried E., Amorim P., Chambers G., Cottrell J.E., Kass I.S. The importance of sodium for anoxic transmission damage in rat hippocampal slices. mechanisms of protection by lidocaine J. Physiol. 489:1995;557-565.
147. Friedel H.A., Fitton A. Flupirtine. A review of its pharmacological properties, and therapeutic efficacy in pain states. Drugs. 45:1993;548-569.
148. Fujino T., Curtin V.T., Norton E.W. Experimental central retinal vein occlusion. A comparison of intraocular and extraocular occlusion. Arch. Ophthalmol. 81:1969;395-406.
149. Fujino T., Hamasaki D.I. Effect of intraocular pressure on the electroretinogram. Arch. Ophthalmol. 78:1967;757-765.
150. 2+- mediated cytotoxicity in PC12 cells. J. Neurosci. Res. 64:2001;661-669.
151. Garthwaite G., Garthwaite J. Receptor-linked ionic channels mediate N-methyl-D-aspartate neurotoxicity in rat cerebellar slices. Neurosci. Lett. 83:1987;241-246.
152. Gehlbach P., Purple R.L. Enhancement of retinal recovery by conjugated deferoxamine after ischemia-reperfusion. Invest. Ophthalmol. Vis. Sci. 35:1994;669-676.
153. George C.P., Goldberg M.P., Choi D.W., Steinberg G.K. Dextromethorphan reduces neocortical ischemic neuronal damage in vivo. Brain Res. 440:1988;375-379.
154. Gerlach R., Beck M., Zeitschel U., Seifert V. MK 801 attenuates c-Fos and c-Jun expression after in vitro ischemia in rat neuronal cell cultures but not in PC 12 cells. Neurol. Res. 24:2002;725-729.
155. Geyer O., Almog J., Lupu-Meiri M., Lazar M., Oron Y. Nitric oxide synthase inhibitors protect rat retina against ischemic injury. FEBS Lett. 374:1995;399-402.
156. Gilgun Sherki Y., Rosenbaum Z., Melamed E., Offen D. Antioxidant therapy in acute central nervous system injury. current state Pharmacol. Rev. 54:2002;271-284.
157. Gladstone D.J., Black S.E., Hakim A.M. Toward wisdom from failure. lessons from neuroprotective stroke trials and new therapeutic directions Stroke. 33:2002;2123-2136.
158. + of anoxic brain vesicles. Neuropharmacology. 35:1996;1743-1752.
159. Goebel D.J., Aurelia J.L., Tai Q., Jojich L., Poosch M.S. Immunocytochemical localization of the NMDA-R2A receptor subunit in the cat retina. Brain Res. 808:1998;141-154.
160. Gohdo T., Ueda H., Ohno S., Iijima H., Tsukahara S. Heat shock protein 70 expression increased in rabbit muller cells in the ischemia-reperfusion model. Ophthalmic Res. 33:2001;298-302.
161. Goldstein I.M., Ostwald P., Roth S. Nitric oxide. a review of its role in retinal function and disease Vision Res. 36:1996;2979-2994.
162. Gonzalez M.I., Lopez-Colom A.M., Ortega A. Sodium-dependent glutamate transport in Muller glial cells. regulation by phorbol esters Brain Res. 831:1999;140-145.
163. Gorelick P.B. Neuroprotection in acute ischaemic stroke. a tale of for whom the bell tolls? Lancet. 355:2000;1925-1926.
164. Goto W., Ota T., Morikawa N., Otori Y., Hara H., Kawazu K., Miyawaki N., Tano Y. Protective effects of timolol against the neuronal damage induced by glutamate and ischemia in the rat retina. Brain Res. 958:2002;10-19.
165. Green A.R., Hainsworth A.H., Jackson D.M. GABA potentiation. a logical pharmacological approach for the treatment of acute ischaemic stroke Neuropharmacology. 39:2000;1483-1494.
166. Green W.R., Chan C.C., Hutchins G.M., Terry J.M. Central retinal vein occlusion. a prospective histopathologic study of 29 eyes in 28 cases Trans. Am. Ophthalmol. Soc. 79:1981;371-422.
167. Griffiths R., Ritchie L., Lidwell K., Grieve A., Malcolm C.S., Scott M., Meredith C. Calcium influx via L-type voltage-gated channels mediates the delayed, elevated increases in steady-state c-fos mRNA levels in cerebellar granule cells exposed to excitotoxic levels of glutamate. J. Neurosci. Res. 52:1998;641-652.
168. Grimm C., Wenzel A., Groszer M., Mayser H., Seeliger M., Samardzija M., Bauer C., Gassmann M., Reme C.E. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat. Med. 8:2002;718-724.
169. Gross R.L., Hensley S.H., Gao F., Yang X.L., Dai S.C., Wu S.M. Effects of betaxolol on light responses and membrane conductance in retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 41:2000;722-728.
170. Grozdanic S.D., Sakaguchi D.S., Kwon Y.H., Kardon R.H., Sonea I.M. Functional characterization of retina and optic nerve after acute ocular ischemia in rats. Invest. Ophthalmol. Vis. Sci. 44:2003;2597-2605.
171. Grunder T., Kohler K., Kaletta A., Guenther E. The distribution and developmental regulation of NMDA receptor subunit proteins in the outer and inner retina of the rat. J. Neurobiol. 44:2000;333-342.
172. Grunert U. Distribution of GABA and glycine receptors on bipolar and ganglion cells in the mammalian retina. Microsc. Res. Tech. 50:2000;130-140.
173. Gupta L.Y., Marmor M.F. Mannitol, dextromethorphan, and catalase minimize ischemic damage to retinal pigment epithelium and retina. Arch Ophthalmol. 111:1993;384-388.
174. Gupta S. Molecular steps of death receptor and mitochondrial pathways of apoptosis. Life Sci. 69:2001;2957-2964.
175. Gwon J.S., Ju W.K., Park S.J., Kim I.B., Lee M.Y., Oh S.J., Chun M.H. The regulatory expression of neuronal nitric oxide synthase in the ischemic rat retina. Neuroreport. 12:2001;3385-3389.
176. Haberecht M.F., Mitchell C.K., Lo G.J., Redburn D.A. N-methyl-D- aspartate-mediated glutamate toxicity in the developing rabbit retina. J. Neurosci. Res. 47:1997;416-426.
177. Hagberg H., Lehmann A., Sandberg M., Nystrom B., Jacobson I., Hamberger A. Ischemia-induced shift of inhibitory and excitatory amino acids from intra- to extracellular compartments. J. Cereb. Blood Flow Metab. 5:1985;413-419.
178. Hallenbeck J.M. The many faces of tumor necrosis factor in stroke. Nat. Med. 8:2002;1363-1368.
179. Hamasaki D.I., Kroll A.J. Experimental central retinal artery occlusion. An electrophysiological study. Arch. Ophthalmol. 80:1968;243-248.
180. Hangai M., Yoshimura N., Yoshida M., Yabuuchi K., Honda Y. Interleukin-1 gene expression in transient retinal ischemia in the rat. Invest. Ophthalmol. Vis. Sci. 36:1995;571-578.
181. Hangai M., Yoshimura N., Hiroi K., Mandai M., Honda Y. Inducible nitric oxide synthase in retinal ischemia-reperfusion injury. Exp. Eye Res. 63:1996;501-509.
182. Hangai M., Yoshimura N., Honda Y. Increased cytokine gene expression in rat retina following transient ischemia. Ophthalmic Res. 28:1996;248-254.
183. Hangai M., Miyamoto K., Hiroi K., Tujikawa A., Ogura Y., Honda Y., Yoshimura N. Roles of constitutive nitric oxide synthase in postischemic rat retina. Invest. Ophthalmol. Vis. Sci. 40:1999;450-458.
184. Hangai M., Yoshimura N., Hiroi K., Mandai M., Honda Y. Role of nitric oxide during the initial phase of reperfusion after retinal ischemia in the rat. Ophthalmic Res. 31:1999;16-23.
185. Hankins M.W., Ikeda H. Consequences of transient retinal hypoxia on rod input to horizontal cells in the rat retina. Vision Res. 33:1993;429-436.
186. Hansen A.J. Effect of anoxia on ion distribution in the brain. Physiol. Rev. 65:1985;101-148.
187. Harding J.J. Biochemistry of the Eye. 1997;Chapman & Hall Medical, London.
188. Hare W., WoldeMussie E., Lai R., Ton H., Ruiz G., Feldmann B., Wijono M., Chun T., Wheeler L. Efficacy and safety of memantine, an NMDA-type open-channel blocker, for reduction of retinal injury associated with experimental glaucoma in rat and monkey. Surv. Ophthalmol. 45(Suppl 3):2001;S284-S289.
189. Harris R.J., Symon L., Branston N.M., Bayhan M. Changes in extracellular calcium activity in cerebral ischaemia. J. Cereb. Blood Flow Metab. 1:1981;203-209.
190. Hartveit E., Brandstatter J.H., Sassoe Pognetto M., Laurie D.J., Seeburg P.H., Wassle H. Localization and developmental expression of the NMDA receptor subunit NR2A in the mammalian retina. J. Comp. Neurol. 348:1994;570-582.
191. Hartveit E., Brandstatter J.H., Enz R., Wassle H. Expression of the mRNA of seven metabotropic glutamate receptors (mGluR1 to 7) in the rat retina. An in situ hybridization study on tissue sections and isolated cells. Eur. J. Neurosci. 7:1995;1472-1483.
192. Hayreh S.S. Pathogenesis of occlusion of the central retinal vessels. Am. J. Ophthalmol. 72:1971;998-1011.
193. Hayreh S.S. So-called "central retinal vein occlusion". I. Pathogenesis, terminology, clinical features. Ophthalmologica. 172:1976;1-13.
194. Hayreh S.S., Weingeist T.A. Experimental occlusion of the central artery of the retina. IV. retinal tolerance time to acute ischaemia Br. J. Ophthalmol. 64:1980;818-825.
195. Hayreh S.S., van Heuven W.A., Hayreh M.S. Experimental retinal vascular occlusion. I. Pathogenesis of central retinal vein occlusion. Arch. Ophthalmol. 96:1978;311-323.
196. Heidinger V., Dreyfus H., Sahel J., Christen Y., Hicks D. Excitotoxic damage of retinal glial cells depends upon normal neuron-glial interactions. Glia. 23:1998;146-155.
197. Henkes H. Electroretinography in circulatory disturbances of the retina. Arch. Ophthalmol. 49:1953;190-201.
198. Hernandez M.R. The optic nerve head in glaucoma. role of astrocytes in tissue remodeling Prog. Retin. Eye Res. 19:2000;297-321.
199. Hirasawa H., Shiells R., Yamada M. A metabotropic glutamate receptor regulates transmitter release from cone presynaptic terminals in carp retinal slices. J. Gen. Physiol. 119:2002;55-68.
200. Hiroi K., Yamamoto F., Honda Y. Intraretinal study of cat electroretinogram during retinal ischemia-reperfusion with extracellular K+ concentration microelectrodes. Invest. Ophthalmol. Vis. Sci. 35:1994;656-663.
201. Hirooka K., Kelly M.E., Baldridge W.H., Barnes S. Suppressive actions of betaxolol on ionic currents in retinal ganglion cells may explain its neuroprotective effects. Exp. Eye Res. 70:2000;611-621.
202. Hofman P., van Blijswijk B.C., Gaillard P.J., Vrensen G.F., Schlingemann R.O. Endothelial cell hypertrophy induced by vascular endothelial growth factor in the retina. new insights into the pathogenesis of capillary nonperfusion Arch. Ophthalmol. 119:2001;861-866.
203. Huang J.C., Salt T.E., Voaden M.J., Marshall J. Non-competitive NMDA-receptor antagonists and anoxic degeneration of the ERG B-wave in vitro. Eye. 5:1991;476-480.
204. Hueber A., Wiedemann P., Esser P., Heimann K. Basic fibroblast growth factor mRNA, bFGF peptide and FGF receptor in epiretinal membranes of intraocular proliferative disorders (PVR and PDR). Int. Ophthalmol. 20:1996;345-350.
205. Hughes W.F. Quantitation of ischemic damage in the rat retina. Exp. Eye Res. 53:1991;573-582.
206. Hughes W.F., Henderson J. Experimental observations on postischemic retinal perfusion using FITC-labelled red cells. relation to vascular leakage and retinal damage in two modes of anaesthesia Invest. Ophthalmol. Vis. Sci. 27:1986;S256.
207. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20:1997;132-139.
208. Ikeda H., Hankins M.W., Asai T., Dawes E.A. Electrophysiological properties of neurones following mild and acute retinal ischaemia. Exp. Eye Res. 55:1992;435-442.
209. Ikeda M., Nakazawa T., Abe K., Kaneko T., Yamatsu K. Extracellular accumulation of glutamate in the hippocampus induced by ischemia is not calcium dependent - in vitro and in vivo evidence. Neurosci. Lett. 96:1989;202-206.
210. Inoue-Matsuhisa E., Sogo S., Mizota A., Taniai M., Takenaka H., Mano T. Effect of MCI-9042, a 5-HT2 receptor antagonist, on retinal ganglion cell death and retinal ischemia. Exp. Eye Res. 76:2003;445-452.
211. Izumi Y., Hammerman S.B., Kirby C.O., Benz A.M., Olney J.W., Zorumski C.F. Involvement of glutamate in ischemic neurodegeneration in isolated retina. Vis. Neurosci. 20:2003;97-107.
212. Jeffries P., Clemett R., Day T. An anotomical study of retinal arteriovenous crossings and their role in the pathogenesis of retinal branch vein occlusion. Aust. N. Z. J. Ophthalmol. 21:1993;213-217.
213. Jehle T., Lagreze W.A., Blauth E., Knorle R., Schnierle P., Lucking C.H., Feuerstein T.J. Gabapentin-lactam (8-aza-spiro[5,4]decan-9-on; GBP-L) inhibits oxygen glucose deprivation-induced [3. H]glutmate release and is a neuroprotective agent in a model of acute retinal ischemia Naunyn Schmiedebergs Arch. Pharmacol. 362:2000;74-81.
214. Jennings R.B., Sommers H.M., Smyth G.A., Flack H.A., Linn H. Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog. Arch. Pathol. 70:1960;68-78.
215. Johnson M.A., McPhee T.J. Electroretinographic findings in iris neovascularization due to acute central retinal vein occlusion. Arch. Ophthalmol. 111:1993;806-814.
216. Johnson N. Retinal glycogen content during ischaemia. Albrecht. Von Graefes Arch. Klin. Exp. Ophthalmol. 283:1977;271-282.
217. Johnson N.F., Grierson I. Post-mortem changes in the rabbit retina. A study by light microscopy. Acta Ophthalmol. 54:1976;529-541.
218. Joo C.K., Choi J.S., Ko H.W., Park K.Y., Sohn S., Chun M.H., Oh Y.J., Gwag B.J. Necrosis and apoptosis after retinal ischemia. involvement of NMDA-mediated excitotoxicity and p53 Invest. Ophthalmol. Vis. Sci. 40:1999;713-720.
219. Ju W.K., Lee M.Y., Hofmann H.D., Kirsch M., Chun M.H. Expression of CNTF in Muller cells of the rat retina after pressure-induced ischemia. Neuroreport. 10:1999;419-422.
220. Ju W.K., Kim K.Y., Hofmann H.D., Kim I.B., Lee M.Y., Oh S.J., Chun M.H. Selective neuronal survival and upregulation of PCNA in the rat inner retina following transient ischemia. J. Neuropathol. Exp. Neurol. 59:2000;241-250.
221. Ju W.K., Kim K.Y., Park S.J., Park D.K., Park C.B., Oh S.J., Chung J.W., Chun M.H. Nitric oxide is involved in sustained and delayed cell death of rat retina following transient ischemia. Brain Res. 881:2000;231-236.
222. Ju W.K., Gwon J.S., Kim K.Y., Oh S.J., Kim S.Y., Chun M.H. Up-regulated eNOS protects blood-retinal barrier in the L-arginine treated ischemic rat retina. Neuroreport. 12:2001;2405-2409.
223. Ju W.K., Kim K.Y., Neufeld A.H. Increased activity of cyclooxygenase-2 signals early neurodegenerative events in the rat retina following transient ischemia. Exp. Eye Res. 77:2003;137-145.
224. Junk A.K., Mammis A., Savitz S.I., Singh M., Roth S., Malhotra S., Rosenbaum P.S., Cerami A., Brines M.et al. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA. 99:2002;10659-10664.
225. Justice J. Jr., Lehmann R.P. Cilioretinal arteries. A study based on review of stereo fundus photographs and fluorescein angiographic findings. Arch. Ophthalmol. 94:1976;1355-1358.
226. Kalloniatis M. Amino acids in neurotransmission and disease. J. Am. Optom. Assoc. 66:1995;750-757.
227. Kapin M.A., Doshi R., Scatton B., DeSantis L.M., Chandler M.L. Neuroprotective effects of eliprodil in retinal excitotoxicity and ischemia. Invest. Ophthalmol. Vis. Sci. 40:1999;1177-1182.
228. Karpe, G., 1945. The basis of clinical electroretinography. Acta Ophthalmol. (Suppl) 24, 1-21.
229. Kaskel D., Hockwin O., Metzler U., Schedtler C.-M. Glycogen content in the rabbit retina in relation to blood circulation. Ophthalmol. Res. 5:1973;177-185.
230. Katai N., Yoshimura N. Apoptotic retinal neuronal death by ischemia-reperfusion is executed by two distinct caspase family proteases. Invest. Ophthalmol. Vis. Sci. 40:1999;2697-2705.
231. Katsura K., Kristian T., Smith M.L., Siesjo B.K. Acidosis induced by hypercapnia exaggerates ischemic brain damage. J. Cereb. Blood Flow Metab. 14:1994;243-250.
232. Kawasaki A., Han M.H., Wei J.Y., Hirata K., Otori Y., Barnstable C.J. Protective effect of arachidonic acid on glutamate neurotoxicity in rat retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 43:2002;1835-1842.
233. Keirstead S.A., Miller R.F. Metabotropic glutamate receptor agonists evoke calcium waves in isolated muller cells. Glia. 21:1997;194-203.
234. Khaliq A., Foreman D., Ahmed A., Weich H., Gregor Z., McLeod D., Boulton M. Increased expression of placenta growth factor in proliferative diabetic retinopathy. Lab. Invest. 78:1998;109-116.
235. Kikuchi M., Kashii S., Honda Y., Ujihara H., Sasa M., Tamura Y., Akaike A. Protective action of zinc against glutamate neurotoxicity in cultured retinal neurons. Invest. Ophthalmol. Vis. Sci. 36:1995;2048-2053.
236. Kim S.Y., Kwak J.S., Shin J.P., Lee S.H. The protection of the retina from ischemic injury by the free radical scavenger EGb 761 and zinc in the cat retina. Ophthalmologica. 212:1998;268-274.
237. + medium causes inhibition of glutamate and aspartate uptake and increases their release. J. Cereb. Blood Flow Metab. 15:1995;409-416.
238. Kincaid M.C., Yanoff M., Fine B.S. Pathology of the eye. Eagle R.C. Duane's Foundations of Clinical Ophthalmology. 1998;6-12 Lippincott Williams and Wilkins, Philadelphia.
239. Kline R.P., Ripps H., Dowling J.E. Generation of b-wave currents in the skate retina. Proc. Natl. Acad. Sci. USA. 75:1978;5727-5731.
240. Kobayashi M., Kuroiwa T., Shimokawa R., Okeda R., Tokoro T. Nitric oxide synthase expression in ischemic rat retinas. Jpn. J. Ophthalmol. 44:2000;235-244.
241. 2+ channel antagonists and neuroprotection from cerebral ischemia. Eur. J. Pharmacol. 363:1998;1-15.
242. Kobayashi T., Kuroda S., Tada M., Houkin K., Iwasaki Y., Abe H. Calcium-induced mitochondrial swelling and cytochrome c release in the brain. its biochemical characteristics and implication in ischemic neuronal injury Brain Res. 960:2003;62-70.
243. Kocur I., Resnikoff S. Visual impairment and blindness in Europe and their prevention. Br. J. Ophthalmol. 86:2002;716-722.
244. Kogure K., Kato H. Altered gene expression in cerebral ischemia. Stroke. 24:1993;2121-2127.
245. Koh J.Y., Suh S.W., Gwag B.J., He Y.Y., Hsu C.Y., Choi D.W. The role of zinc in selective neuronal death after transient global cerebral ischemia. Science. 272:1996;1013-1016.
246. 2+ block via activation of voltage independent potassium channels Rapid communication. J. Neural Transm. 106:1999;857-867.
247. Kovalchuk Y., Miller B., Sarantis M., Attwell D. Arachidonic acid depresses non-NMDA receptor currents. Brain Res. 643:1994;287-295.
248. Kramer R.M., Stephenson D.T., Roberts E.F., Clemens J.A. Cytosolic phospholipase. A2 (cPLA2) and lipid mediator release in the brain. J. Lipid Mediat. Cell Signal. 14:1996;3-7.
249. Kristian T., Siesjo B.K. Calcium in ischemic cell death. Stroke. 29:1998;705-718.
250. Kudo I., Murakami M. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat. 68-69:2002;3-58.
251. 2+ changes induced by in vitro ischemia in rat retinal slices. Exp. Eye Res. 73:2001;365-374.
252. Kuriyama H., Waki M., Nakagawa M., Tsuda M. Involvement of oxygen free radicals in experimental retinal ischemia and the selective vulnerability of retinal damage. Ophthalmic Res. 33:2001;196-202.
253. Kuroiwa S., Katai N., Shibuki H., Kurokawa T., Umihira J., Nikaido T., Kametani K., Yoshimura N. Expression of cell cycle-related genes in dying cells in retinal ischemic injury. Invest. Ophthalmol. Vis. Sci. 39:1998;610-617.
254. Kurokawa T., Katai N., Shibuki H., Kuroiwa S., Kurimoto Y., Nakayama C., Yoshimura N. BDNF diminishes caspase-2 but not c-Jun immunoreactivity of neurons in retinal ganglion cell layer after transient ischemia. Invest. Ophthalmol. Vis. Sci. 40:1999;3006-3011.
255. Kuwabara T., Cogan D. Retinal glycogen. Arch. Ophthalmol. 66:1961;96-104.
256. Kwong J.M., Lam T.T., Caprioli J. Hyperthermic pre-conditioning protects retinal neurons from N-methyl-D-aspartate (NMDA)-induced apoptosis in rat. Brain Res. 970:2003;119-130.
257. 2-selective adrenergic agonists against ischemia-induced retinal ganglion cell death. Invest. Ophthalmol. Vis. Sci. 42:2001;2074-2084.
258. Lafuente M.P., Villegas-Perez M.P., Mayor S., Aguilera M.E., Miralles de Imperial J., Vidal-Sanz M. Neuroprotective effects of brimonidine against transient ischemia-induced retinal ganglion cell death. a dose response in vivo study Exp. Eye Res. 74:2002;181-189.
259. Lafuente M.P., Villegas-Perez M.P., Sells-Navarro I., Mayor-Torroglosa S., Miralles de Imperial J., Vidal-Sanz M. Retinal ganglion cell death after acute retinal ischemia is an ongoing process whose severity and duration depends on the duration of the insult. Neuroscience. 109:2002;157-168.
260. Lagreze W.A., Knorle R., Bach M., Feuerstein T.J. Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. Invest. Ophthalmol. Vis. Sci. 39:1998;1063-1066.
261. Lai R.K., Chun T., Hasson D., Lee S., Mehrbod F., Wheeler L. Alpha-2 adrenoceptor agonist protects retinal function after acute retinal ischemic injury in the rat. Vis. Neurosci. 19:2002;175-185.
262. Lam T.T. The effect of 3-aminobenzamide, an inhibitor of poly ADP-ribose polymerase, on ischemia/reperfusion damage in rat retina. Res. Commun. Mol. Pathol. Pharmacol. 95:1997;241-252.
263. Lam T.T., Tso M.O. Nitric oxide synthase (NOS) inhibitors ameliorate retinal damage induced by ischemia in rats. Res. Commun. Mol. Pathol. Pharmacol. 92:1996;329-340.
264. Lam T.T., Fu J., Hrynewycz M., Tso M.O. The effect of aurintricarboxylic acid, an endonuclease inhibitor, on ischemia/reperfusion damage in rat retina. J. Ocul. Pharmacol. Ther. 11:1995;253-259.
265. Lam T.T., Siew E., Chu R., Tso M.O. Ameliorative effect of MK-801 on retinal ischemia. J. Ocul. Pharmacol. Ther. 13:1997;129-137.
266. Lam T.T., Abler A.S., Tso M.O. Apoptosis and caspases after ischemia-reperfusion injury in rat retina. Invest. Ophthalmol. Vis. Sci. 40:1999;967-975.
267. Larsen A.K., Osborne N.N. Involvement of adenosine in retinal ischemia. Studies on the rat. Invest. Ophthalmol. Vis. Sci. 37:1996;2603-2611.
268. Le Bars P.L., Katz M.M., Berman N., Itil T.M., Freedman A.M., Schatzberg A.F. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA. 278:1997;1327-1332.
269. Lee J.M., Zipfel G.J., Choi D.W. The changing landscape of ischaemic brain injury mechanisms. Nature. 399:1999;A7-14.
270. Lee J.M., Zipfel G.J., Park K.H., He Y.Y., Hsu C.Y., Choi D.W. Zinc translocation accelerates infarction after mild transient focal ischemia. Neuroscience. 115:2002;871-878.
271. Lee J.Y., Kim Y.H., Koh J.Y. Protection by pyruvate against transient forebrain ischemia in rats. J. Neurosci. 21:2001;171.
272. Lees G.J. Inhibition of sodium-potassium-ATPase. a potentially ubiquitous mechanism contributing to central nervous system neuropathology Brain Res. Brain Res. Rev. 16:1991;283-300.
273. Lees G.J. Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders. Drugs. 59:2000;33-78.
274. Lees G.J., Leong W. Differential effects of NBQX on the distal and local toxicity of glutamate agonists administered intra-hippocampally. Brain Res. 628:1993;1-7.
275. Lees K.R. Advances in neuroprotection trials. Eur. Neurol. 45:2001;6-10.
276. Leker R.R., Shohami E. Cerebral ischemia and trauma-different etiologies yet similar mechanisms. neuroprotective opportunities Brain Res. Rev. 39:2002;55-73.
277. Levi G., Patrizio M. Astrocyte heterogeneity. endogenous amino acid levels and release evoked by non-N-methyl-D-aspartate receptor agonists and by potassium-induced swelling in type-1 and type-2 astrocytes J. Neurochem. 58:1992;1943-1952.
278. Lewden O., Garcher C., Morales C., Javouhey A., Rochette L., Bron A.M. Changes of catalase activity after ischemia-reperfusion in rat retina. Ophthalmic Res. 28:1996;331-335.
279. Lewden O., Garcher C., Assem M., Morales C., Rochette L., Bron A.M. Changes of the inducible heat shock protein 70 mRNA level in rat retina after ischemia and reperfusion. Ophthalmic Res. 30:1998;291-294.
280. Li B., Roth S. Retinal ischemic preconditioning in the rat. requirement for adenosine and repetitive induction Invest. Ophthalmol. Vis. Sci. 40:1999;1200-1216.
281. Li B., Yang C., Rosenbaum D.M., Roth S. Signal transduction mechanisms involved in ischemic preconditioning in the rat retina in vivo. Exp. Eye Res. 70:2000;755-765.
282. Li J., Kato K., Ikeda J., Morita I., Murota S. A narrow window for rescuing cells by the inhibition of calcium influx and the importance of influx route in rat cortical neuronal cell death induced by glutamate. Neurosci. Lett. 304:2001;29-32.
283. Li Y., Schlamp C.L., Poulsen G.L., Jackson M.W., Griep A.E., Nickells R.W. p53 regulates apoptotic retinal ganglion cell death induced by N-methyl-D-aspartate. Mol. Vis. 8:2002;341-350.
284. Li Y., Roth S., Laser M., Ma J.X., Crosson C.E. Retinal preconditioning and the induction of heat-shock protein 27. Invest. Ophthalmol. Vis. Sci. 44:2003;1299-1304.
285. Liebeskind D.S., Kasner S.E. Neuroprotection for ischaemic stroke. an unattainable goal? CNS Drugs. 15:2001;165-174.
286. Limb G.A., Salt T.E., Munro P.M., Moss S.E., Khaw P.T. In vitro characterization of a spontaneously immortalized human Muller cell line (MIO-M1). Invest. Ophthalmol. Vis. Sci. 43:2002;864-869.
287. 2+ sequestration/extrusion mechanisms following excitotoxic glutamate exposure. Brain Res. 894:2001;56-67.
288. Lin B., Martin P.R., Grunert U. Expression and distribution of ionotropic glutamate receptor subunits on parasol ganglion cells in the primate retina. Vis. Neurosci. 19:2002;453-465.
289. Lin J., Roth S. Ischemic preconditioning attenuates hypoperfusion after retinal ischemia in rats. Invest. Ophthalmol. Vis. Sci. 40:1999;2925-2931.
290. Liou A.K., Clark R.S., Henshall D.C., Yin X.M., Chen J. To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy. a review on the stress-activated signaling pathways and apoptotic pathways Prog. Neurobiol. 69:2003;103-142.
291. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 79:1999;1431-1568.
292. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330:1994;613-622.
293. Lipton S.A., Singel D.J., Stamler J.S. Nitric oxide in the central nervous system. Prog. Brain Res. 103:1994;359-364.
294. Lo E.H., Steinberg G.K. Effects of dextromethorphan on regional cerebral blood flow in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 11:1991;803-809.
295. Lo E.H., Hara H., Rogowska J., Trocha M., Pierce A.R., Huang P.L., Fishman M.C., Wolf G.L., Moskowitz M.A. Temporal correlation mapping analysis of the hemodynamic penumbra in mutant mice deficient in endothelial nitric oxide synthase gene expression. Stroke. 27:1996;1381-1385.
296. Lobner D., Lipton P. Intracellular calcium levels and calcium fluxes in the CA1 region of the rat hippocampal slice during in vitro ischemia. relationship to electrophysiological cell damage J. Neurosci. 13:1993;4861-4871.
297. Lombardi G., Moroni F., Moroni F. Glutamate receptor antagonists protect against ischemia-induced retinal damage. Eur. J. Pharmacol. 271:1994;489-495.
298. Lopez Colome A.M., Fragoso G., Wright C.E., Sturman J.A. Excitatory amino acid receptors in membranes from cultured human retinal pigment epithelium. Curr. Eye Res. 13:1994;553-560.
299. Lopez-Costa J.J., Goldstein J., Saavedra J.P. Neuronal and macrophagic nitric oxide synthase isoforms distribution in normal rat retina. Neurosci. Lett. 232:1997;155-158.
300. Louzada-Junior P., Dias J.J., Santos W.F., Lachat J.J., Bradford H.F., Coutinho-Netto J. Glutamate release in experimental ischaemia of the retina. an approach using microdialysis J. Neurochem. 59:1992;358-363.
301. Lucas D.R., Newhouse J.P. The toxic effect of sodium L-glutamate on the inner layers of the retina. Arch. Ophthalmol. 58:1957;193-201.
302. Lundy E.F., Luyckx B.A., Combs D.J., Zelenock G.B., D'Alecy L.G. Butanediol induced cerebral protection from ischemic-hypoxia in the instrumented Levine rat. Stroke. 15:1984;547-552.
303. Luo F.J., Liang P.J. Metabotropic glutamate receptor-mediated hetero-synaptic interaction of red- and green-cone inputs to LHC of carp retina. Brain Res. Bull. 60:2003;67-71.
304. Luo X., Heidinger V., Picaud S., Lambrou G., Dreyfus H., Sahel J., Hicks D. Selective excitotoxic degeneration of adult pig retinal ganglion cells in vitro. Invest. Ophthalmol. Vis. Sci. 42:2001;1096-1106.
305. Lutty G.A., McLeod D.S. Retinal vascular development and oxygen-induced retinopathy. a role for adenosine Prog. Retin. Eye Res. 22:2003;95-111.
306. Madl J.E., Burgesser K. Adenosine triphosphate depletion reverses sodium-dependent, neuronal uptake of glutamate in rat hippocampal slices. J. Neurosci. 13:1993;4429-4444.
307. Maguire G., Simko H., Weinreb R.N., Ayoub G. Transport-mediated release of endogenous glutamate in the vertebrate retina. Pflugers Arch. 436:1998;481-484.
308. Mans A.M., DeJoseph M.R., Davis D.W., Hawkins R.A. Brain energy metabolism in streptozotocin-diabetes. Biochem. J. 249:1988;57-62.
309. Marc R.E. Kainate activation of horizontal, bipolar, amacrine, and ganglion cells in the rabbit retina. J. Comp. Neurol. 407:1999;65-76.
310. Marmor M.F., Dalal R. Irregular retinal and RPE damage after pressure-induced ischemia in the rabbit. Invest. Ophthalmol. Vis. Sci. 34:1993;2570-2575.
311. Martins-Ferreira H., Nedergaard M., Nicholson C. Perspectives on spreading depression. Brain Res. Rev. 32:2000;215-234.
312. Massey S.C. Cell types using glutamate as a neurotransmitter in the vertebrate retina. Osborne N.N., Chader G.J. Progress in Retinal Research. 1990;399-425 Pergamon Press, Oxford.
313. Matsubara M., Hayashi N., Jing T., Titani K. Regulation of endothelial nitric oxide synthase by protein kinase C. J. Biochem. (Tokyo). 133:2003;773-781.
314. Matsuo Y., Kihara T., Ikeda M., Ninomiya M., Onodera H., Kogure K. Role of neutrophils in radical production during ischemia and reperfusion of the rat brain. effect of neutrophil depletion on extracellular ascorbyl radical formation J. Cereb. Blood Flow Metab. 15:1995;941-947.
315. Maxwell P.H., Ratcliffe P.J. Oxygen sensors and angiogenesis. Semin. Cell Dev. Biol. 13:2002;29-37.
316. Maynard K.I., Chen D., Arango P.M., Ogilvy C.S. Nitric oxide produced during ischemia improves functional recovery in the rabbit retina. Neuroreport. 8:1996;81-85.
317. Maynard K.I., Quinones-Hinojosa A., Malek J.Y. Neuroprotection against ischemia by metabolic inhibition revisited. A comparison of hypothermia a pharmacologic cocktail and magnesium plus mexiletine. Ann. NY Acad. Sci. 890:1999;240-254.
318. McClellan K.J., Plosker G.L. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions. Drugs. 58:1999;143-157.
319. McDonald J.W., Silverstein F.S., Johnston M.V. Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system. Brain Res. 459:1988;200-203.
320. Melena J., Osborne N.N. Voltage-dependent calcium channels in the rat retina. involvement in NMDA-stimulated influx of calcium Exp. Eye Res. 72:2001;393-401.
321. 2+ channels. Eur. J. Pharmacol. 378:1999;317-322.
322. Melena J., Stanton D., Osborne N.N. Comparative effects of antiglaucoma drugs on voltage-dependent calcium channels. Graefes Arch. Clin. Exp. Ophthalmol. 239:2001;522-530.
323. Melena J., Safa R., Graham M., Casson R.J., Osborne N.N. The monocarboxylate transport inhibitor, alpha-cyano-4-hydroxycinnamate, has no effect on retinal ischemia. Brain Res. 989:2003;128-134.
324. Meyer F.B., Anderson R.E., Sundt T.M. Jr., Yaksh T.L. Intracellular brain pH, indicator tissue perfusion, electroencephalography, and histology in severe and moderate focal cortical ischemia in the rabbit. J. Cereb. Blood Flow Metab. 6:1986;71-78.
325. Michaelson I.C. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans. Ophthalmol. Soc. UK. 68:1948;137-180.
326. Michaelson I.C. Retinal Circulation in Man and Animals. 1954;Charles C. Thomas, Springfield.
327. Mignatti P., Rifkin D.B. Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein. 49:1996;117-137.
328. Mignotte B., Vayssiere J.L. Mitochondria and apoptosis. Eur. J. Biochem. 252:1998;1-15.
329. Miller B., Sarantis M., Traynelis S.F., Attwell D. Potentiation of NMDA receptor currents by arachidonic acid. Nature. 355:1992;722-725.
330. Miller J.W., Adamis A.P., Shima D.T., D'Amore P.A., Moulton R.S., O'Reilly M.S., Folkman J., Dvorak H.F., Brown L.F.et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am. J. Pathol. 145:1994;574-584.
331. 2+ permeability of AMPA-selective glutamate receptor channels. Biochem. Biophys. Res. Commun. 180:1991;813-821.
332. Mitchell P., Smith W., Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch. Ophthalmol. 114:1996;1243-1247.
333. Miyashiro M., Ogata N., Takahashi K., Matsushima M., Yamamoto C., Yamada H., Uyama M. Expression of basic fibroblast growth factor and its receptor mRNA in retinal tissue following ischemic injury in the rat. Graefes Arch. Clin. Exp. Ophthalmol. 236:1998;295-300.
334. Mizushima H., Zhou C.J., Dohi K., Horai R., Asano M., Iwakura Y., Hirabayashi T., Arata S., Nakajo S.et al. Reduced postischemic apoptosis in the hippocampus of mice deficient in interleukin. J. Comp. Neurol. 448:2002;203-216.
335. Mohand-Said S., Jacquet A., Lucien A., Espinasse-Berrod M.A., Frasson Correa De Silva M., Sahel J. Protective effect of trimetazidine in a model of ischemia-reperfusion in the rat retina. Ophthalmic Res. 34:2002;300-305.
336. Morgan, I.G., 1983. Kainic acid as a tool in retinal research. In: Osborne, N.N., Chader, G.J. (Eds.), Progress in Retinal Research, Vol. 2. Pergamon Press, Oxford, pp. 249-266.
337. Morgan J.E. Optic nerve head structure in glaucoma. astrocytes as mediators of axonal damage Eye. 14(Pt 3B):2000;437-444.
338. Mori H., Mishina M. Structure and function of the NMDA receptor channel. Neuropharmacology. 34:1995;1219-1237.
339. Morin D., Hauet T., Spedding M., Tillement J. Mitochondria as target for antiischemic drugs. Adv. Drug Deliv. Rev. 49:2001;151-174.
340. Mosinger J.L., Price M.T., Bai H.Y., Xiao H., Wozniak D.F., Olney J.W. Blockade of both NMDA and non-NMDA receptors is required for optimal protection against ischemic neuronal degeneration in the in vivo adult mammalian retina. Exp. Neurol. 113:1991;10-17.
341. Muir K.W. Heterogeneity of stroke pathophysiology and neuroprotective clinical trial design. Stroke. 33:2002;1545-1550.
342. Muller A., Pietri S., Villain M., Frejaville C., Bonne C., Culcas M. Free radicals in rabbit retina under ocular hyperpressure and functional consequences. Exp. Eye Res. 64:1997;637-643.
343. Murayama K., Yoneya S., Miyauchi O., Adachi-Usami E., Nishikawa M. Fish oil (polyunsaturated fatty acid) prevents ischemic-induced injury in the mammalian retina. Exp. Eye Res. 74:2002;671-676.
344. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia. a delay of lethal cell injury in ischemic myocardium Circulation. 74:1986;1124-1136.
345. Nakamichi N., Chidlow G., Osborne N.N. Effects of intraocular injection of a low concentration of zinc on the rat retina. Neuropharmacology. 45:2003;637-648.
346. Napper G.A., Kalloniatis M. Neurochemical changes following postmortem ischemia in the rat retina. Vis. Neurosci. 16:1999;1169-1180.
347. Napper G.A., Pianta M.J., Kalloniatis M. Reduced glutamate uptake by retinal glial cells under ischemic/hypoxic conditions. Vis. Neurosci. 16:1999;149-158.
348. Nash M.S., Osborne N.N. Assessment of Thy-1 mRNA levels as an index of retinal ganglion cell damage. Invest. Ophthalmol. Vis. Sci. 40:1999;1293-1298.
349. Nash M.S., Wood J.P.M., Melena J., Osborne N.N. Flupirtine ameliorates ischaemic-like death of rat retinal ganglion cells by preventing calcium influx. Brain Res. 856:2000;236-239.
350. Nayak M.S., Marmor M.F. Post-ischemia ERG recovery is influenced by temperature. Curr. Eye Res. 14:1995;81-85.
351. Nayak M.S., Kita M., Marmor M.F. Protection of rabbit retina from ischemic injury by superoxide dismutase and catalase. Invest. Ophthalmol. Vis. Sci. 34:1993;2018-2022.
352. Neal M.J., Cunningham J.R., Hutson P.H., Hogg J. Effects of ischaemia on neurotransmitter release from the isolated retina. J. Neurochem. 62:1994;1025-1033.
353. Nedergaard M. Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. Science. 263:1994;1768-1771.
354. Nedergaard M., Hansen A.J. Characterization of cortical depolarizations evoked in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 13:1993;568-574.
355. Nehlig A., Pereira de Vasconcelos A. Glucose and ketone body utilization by the brain of neonatal rats. Prog. Neurobiol. 40:1993;163-221.
356. Nemoto E.M., Klementavicius R., Melick J.A., Yonas H. Suppression of cerebral metabolic rate for oxygen (CMRO2) by mild hypothermia compared with thiopental. J. Neurosurg. Anesthesiol. 8:1996;52-59.
357. Neubauer J.A. Anoxia? Don't get excited! J. Clin. Invest. 91:1993;377.
358. Neufeld A.H., Sawada A., Becker B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc. Natl. Acad. Sci. USA. 96:1999;9944-9948.
359. Neufeld A.H., Kawai S., Das S., Vora S., Gachie E., Connor J.R., Manning P.T. Loss of retinal ganglion cells following retinal ischemia. the role of inducible nitric oxide synthase Exp. Eye Res. 75:2002;521-528.
360. Nichols C.W., Lambertsen C. Effects of high oxygen pressures on the eye. N. Engl. J. Med. 281:1969;25-30.
361. Nicholson C., Bruggencate G.T., Steinberg R., Stockle H. Calcium modulation in brain extracellular microenvironment demonstrated with ion-selective micropipette. Proc. Natl. Acad. Sci. USA. 74:1977;1287-1290.
362. Nicoletti F., Bruno V., Copani A., Casabona G., Knopfel T. Metabotropic glutamate receptors. a new target for the therapy of neurodegenerative disorders? Trends Neurosci. 19:1996;267-271.
363. Nicotera P., Orrenius S. The role of calcium in apoptosis. Cell Calcium. 23:1998;173-180.
364. Nicotera P., Leist M., Manzo L. Neuronal cell death. a demise with different shapes Trends Pharmacol. Sci. 20:1999;46-51.
365. Nishizawa Y. Glutamate release and neuronal damage in ischemia. Life Sci. 69:2001;369-381.
366. +-channel down-modulation versus presynaptic glutamate release inhibition Rev. Neurosci. 9:1998;203-211.
367. Obrenovitch T.P., Scheller D., Matsumoto T., Tegtmeier F., Holler M., Symon L. A rapid redistribution of hydrogen ions is associated with depolarization and repolarization subsequent to cerebral ischemia reperfusion. J. Neurophysiol. 64:1990;1125-1133.
368. Ogata T., Nakamura Y., Tsuji K., Shibata T., Kataoka K. A possible mechanism for the hypoxia-hypoglycemia-induced release of excitatory amino acids from cultured hippocampal astrocytes. Neurochem. Res. 20:1995;737-743.
369. Ogata N., Wang L., Jo N., Tombran-Tink J., Takahashi K., Mrazek D., Matsumura M. Pigment epithelium derived factor as a neuroprotective agent against ischemic retinal injury. Curr. Eye Res. 22:2001;245-252.
370. Ohtaki H., Funahashi H., Dohi K., Oguro T., Horai R., Asano M., Iwakura Y., Yin L., Matsunaga M.et al. Suppression of oxidative neuronal damage after transient middle cerebral artery occlusion in mice lacking interleukin-1. Neurosci. Res. 45:2003;313-324.
371. Oliver C.N., Starke-Reed P.E., Stadtman E.R., Liu G.J., Carney J.M., Floyd R.A. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc. Natl. Acad. Sci. USA. 87:1990;5144-5147.
372. Olney J.W., Price M.T., Samson L., Labruyere J. The role of specific ions in glutamate neurotoxicity. Neurosci. Lett. 65:1986;65-71.
373. Olney J., Price M., Salles K.S., Labruyere J., Frierdich G. MK 801 powerfully protects against N-methyl aspartate neurotoxicity. Eur. J. Pharmacol. 141:1987;357-361.
374. Olney J.W., Price M.T., Salles K.S., Labruyere J., Ryerson R., Mahan K., Frierdich G., Samson L. L-homocysteic acid. an endogenous excitotoxic ligand of the NMDA receptor Brain Res. Bull. 19:1987;597-602.
375. Olson M., Kornbluth S. Mitochondria in apoptosis and human disease. Curr. Mol. Med. 1:2001;91-122.
376. Ophir A., Berenshtein E., Kitrossky N., Berman E.R., Photiou S., Rothman Z., Chevion M. Hydroxyl radical generation in the cat retina during reperfusion following ischemia. Exp. Eye Res. 57:1993;351-357.
377. Ophir A., Berenshtein E., Kitrossky N., Averbukh E. Protection of the transiently ischemic cat retina by zinc-desferrioxamine. Invest. Ophthalmol. Vis. Sci. 35:1994;1212-1222.
378. O'Regan M.H., Song D., VanderHeide S.J., Phillis J.W. Free radicals and the ischemia-evoked extracellular accumulation of amino acids in rat cerebral cortex. Neurochem. Res. 22:1997;273-280.
379. Orgul S., Cioffi G.A., Wilson D.J., Bacon D.R., Van Buskirk E.M. An endothelin-1 induced model of optic nerve ischemia in the rabbit. Invest. Ophthalmol. Vis. Sci. 37:1996;1860-1869.
380. Orlando L.R., Alsdorf S.A., Penney J.B. Jr., Young A.B. The role of group I and group II metabotropic glutamate receptors in modulation of striatal NMDA and quinolinic acid toxicity. Exp. Neurol. 167:2001;196-204.
381. Osborne N.N. Memantine reduces alterations to the mammalian retina, in situ, induced by ischemia. Vis. Neurosci. 16:1999;45-52.
382. Osborne N.N., Herrera A.J. The effect of experimental ischaemia and excitatory amino acid agonists on the GABA and serotonin immunoreactivities in the rabbit retina. Neuroscience. 59:1994;1071-1081.
383. Osborne N.N., Larsen A.K. Antigens associated with specific retinal cells are affected by ischaemia caused by raised intraocular pressure. effect of glutamate antagonists Neurochem. Int. 29:1996;263-270.
384. Osborne N.N., Block F., Sontag K.H. Reduction of ocular blood flow results in glial fibrillary acidic protein (GFAP) expression in rat retinal muller cells. Vis. Neurosci. 7:1991;637-639.
385. Osborne N.N., Pergande G., Block F., Schwarz M. Immunohistochemical evidence for flupirtine acting as an antagonist on the N-methyl-D-aspartate and homocysteic acid-induced release of GABA in the rabbit retina. Brain Res. 667:1994;291-294.
386. Osborne N.N., McCord R.J., Wood J.P.M. The effect of kainate on protein kinase C, GABA, and the uptake of serotonin in the rabbit retina in vivo. Neurochem. Res. 20:1995;635-641.
387. Osborne N.N., Wood J.P.M., Muller A. The influence of experimental ischaemia on protein kinase c and the Gabaergic system in the rabbit retina. Neuropharmacology. 34:1995;1279-1288.
388. Osborne N.N., Schwarz M., Pergande G. Protection of rabbit retina from ischemic injury by flupirtine. Invest. Ophthalmol. Vis. Sci. 37:1996;274-280.
389. Osborne N.N., Cazevieille C., Carvalho A.L., Larsen A.K., DeSantis L. In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent. Brain Res. 751:1997;113-123.
390. Osborne N.N., Cazevieille C., Wood J.P.M., Nash M.S., Pergande G., Block F., Kosinski C., Schwarz M. Flupirtine, a nonopioid centrally acting analgesic, acts as an NMDA antagonist. Gen. Pharmacol. 30:1998;255-263.
391. Osborne N.N., DeSantis L., Bae J.H., Ugarte M., Wood J.P.M., Nash M.S., Chidlow G. Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina. Exp. Eye Res. 69:1999;331-342.
392. Osborne N.N., Safa R., Nash M.S. Photoreceptors are preferentially affected in the rat retina following permanent occlusion of the carotid arteries. Vision Res. 39:1999;3995-4002.
393. Osborne N.N., Ugarte M., Chao M., Chidlow G., Bae J.H., Wood J.P.M., Nash M.S. Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv. Ophthalmol. 43(Suppl. 1):1999;102-128.
394. Osborne N.N., Wood J.P.M., Chidlow G., Bae J.H., Melena J., Nash M.S. Ganglion cell death in glaucoma. what do we really know? Br. J. Ophthalmol. 83:1999;980-986.
395. 1A agonists. potential use in glaucoma Evidence from animal studies. Eye. 14(Pt 3B):2000;454-463.
396. Osborne N.N., Melena J., Chidlow G., Wood J.P.M. A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head. possible implication for the treatment of glaucoma Br. J. Ophthalmol. 85:2001;1252-1259.
397. Osborne N.N., Wood J.P.-M., Cupido A., Melena J., Chidlow G. Topical flunarizine reduces IOP and protects the retina against ischemia-excitotoxicity. Invest. Ophthalmol. Vis. Sci. 43:2002;1456-1464.
398. Otori Y., Shimada S., Morimura H., Ishimoto I., Tohyama M., Tano Y. Expression of c-fos and c-jun mRNA following transient retinal ischemia. an approach using ligation of the retinal central artery in the rat Surv. Ophthalmol. 42(Suppl 1):1997;S96-S104.
399. Otori Y., Wei J.Y., Barnstable C.J. Neurotoxic effects of low doses of glutamate on purified rat retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 39:1998;972-981.
400. Ozden S., Kildaci B., Muftuoglu S., Cakar N., Yildirim C. Effect of trimetazidine on retinal ischemia/reperfusion injury in rats. Ophthalmologica. 215:2001;309-317.
401. Packer M.A., Murphy M.P. Peroxynitrite formed by simultaneous nitric oxide and superoxide generation causes cyclosporin-A-sensitive mitochondrial calcium efflux and depolarisation. Eur. J. Biochem. 234:1995;231-239.
402. Paques M., Massin P., Gaudric A. Growth factors and diabetic retinopathy. Diabetes Metab. 23:1997;125-130.
403. Paques M., Vallee J.N., Herbreteau D., Aymart A., Santiago P.Y., Campinchi-Tardy F., Payen D., Merlan J.J., Gaudric A.et al. Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion. Br. J. Ophthalmol. 84:2000;1387-1391.
404. Parsons C.G., Gruner R., Rozental J., Millar J., Lodge D. Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan). Neuropharmacology. 32:1993;1337-1350.
405. Paschen W. Role of calcium in neuronal cell injury. which subcellular compartment is involved? Brain Res. Bull. 53:2000;409-413.
406. Patel H.C., Boutin H., Allan S.M. Interleukin-1 in the brain. mechanisms of action in acute neurodegeneration Ann. NY Acad. Sci. 992:2003;39-47.
407. Peachey N.S., Green D.J., Ripps H. Ocular ischemia and the effects of allopurinol on functional recovery in the retina of the arterially perfused cat eye. Invest. Ophthalmol. Vis. Sci. 34:1993;58-65.
408. Pellegrini Giampietro D.E., Cherici G., Alesiani M., Carla V., Moroni F. Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. J. Neurosci. 10:1990;1035-1041.
409. Pellegrini-Giampietro D.E., Cozzi A., Peruginelli F., Leonardi P., Meli E., Pellicciari R., Moroni F. 1-Aminoindan-1,5-dicarboxylic acid and (S)-(+)-2-(3-carboxybicyclo[1.1.1] pentyl)-glycine, two mGlu1 receptor-preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischaemia. Eur. J. Neurosci. 11:1999;3637-3647.
410. Pellerin L. Lactate as a pivotal element in neuron-glia metabolic cooperation. Neurochem. Int. 43:2003;331-338.
411. Pellerin L., Bonvento G., Chatton J.Y., Pierre K., Magistretti P.J. Role of neuron-glia interaction in the regulation of brain glucose utilization. Diabetes Nutr. Metab. 15:2002;268-273.
412. Peng Y.W., Blackstone C.D., Huganir R.L., Yau K.W. Distribution of glutamate receptor subtypes in the vertebrate retina. Neuroscience. 66:1995;483-497.
413. Pereira Neves L., Ribeiro da Silva J. Electrophysiology in pseudohistoplasmosis and chronic idiopathic retinal vasculitis. Eur. J. Ophthalmol. 2:1992;179-189.
414. Perez M.T., Davanger S. Distribution of GABA immunoreactivity in kainic acid-treated rabbit retina. Exp. Brain Res. 100:1994;227-238.
415. Perlman J.I., McCole S.M., Pulluru P., Chang C.J., Lam T.T., Tso M.O. Disturbances in the distribution of neurotransmitters in the rat retina after ischemia. Curr. Eye Res. 15:1996;589-596.
416. Peterson C., Neal J.H., Cotman C.W. Development of N-methyl-D-aspartate excitotoxicity in cultured hippocampal neurons. Brain Res. Dev. Brain Res. 48:1989;187-195.
417. Petito C.K., Chung M.C., Verkhovsky L.M., Cooper A.J. Brain glutamine synthetase increases following cerebral ischemia in the rat. Brain Res. 569:1992;275-280.
418. Petty M.A., Wettstein J.G. White matter ischaemia. Brain Res. Rev. 31:1999;58-64.
419. Phan T.G., Wright P.M., Markus R., Howells D.W., Davis S.M., Donnan G.A. Salvaging the ischaemic penumbra. more than just reperfusion? Clin. Exp. Pharmacol. Physiol. 29:2002;1-10.
420. Picaud S., Larsson H.P., Wellis D.P., Lecar H., Werblin F. Cone photoreceptors respond to their own glutamate release in the tiger salamander. Proc. Natl. Acad. Sci. USA. 92:1995;9417-9421.
421. Poitry S., Poitry Yamate C., Ueberfeld J., MacLeish P.R., Tsacopoulos M. Mechanisms of glutamate metabolic signaling in retinal glial (Muller) cells. J. Neurosci. 20:2000;1809-1821.
422. Poitry Yamate C.L., Poitry S., Tsacopoulos M. Lactate released by Muller glial cells is metabolized by photoreceptors from mammalian retina. J. Neurosci. 15:1995;5179-5191.
423. Poljakovic M., Nygren J.M., Persson K. Signalling pathways regulating inducible nitric oxide synthase expression in human kidney epithelial cells. Eur. J. Pharmacol. 469:2003;21-28.
424. Popp C. Die Retinafunktion nach intraokularer Ischemie. Albrecht. Von Graefes Arch. Klin. Exp. Ophthalmol. 156:1955;395-403.
425. Price M.T., Olney J.W., Samson L., Labruyere J. Calcium influx accompanies but does not cause excitotoxin-induced neuronal necrosis in retina. Brain Res. Bull. 14:1985;369-376.
426. Prince J.H. The Rabbit in Eye Research. 1964;C.C.Thomas, Springfield, IL.
427. Quinones Hinojosa A., Ames A., Malek J.Y., Maynard K.I. An in vitro rabbit retina model to study electrophysiologic and metabolic function during and following ischemia. J. Neurosci. Methods. 90:1999;107-115.
428. Quinones-Hinojosa A., Malek J.Y., Ames A., Ogilvy C.S., Maynard K.I. Metabolic effects of hypothermia and its neuroprotective effects on the recovery of metabolic and electrophysiological function in the ischemic retina in vitro. Neurosurgery. 52:2003;1178-1186.
429. Rahmani B., Tielsch J.M., Katz J., Gottsch J., Quigley H., Javitt J., Sommer A. The cause-specific prevalence of visual impairment in an urban population. The Baltimore Eye Survey. Ophthalmology. 103:1996;1721-1726.
430. Recchia F.M., Brown G.C. Systemic disorders associated with retinal vascular occlusion. Curr. Opin. Ophthalmol. 11:2000;462-467.
431. Rego A.C., Santos M.S., Oliveira C.R. Oxidative stress, hypoxia, and ischemia-like conditions increase the release of endogenous amino acids by distinct mechanisms in cultured retinal cells. J. Neurochem. 66:1996;2506-2516.
432. Reinecke R., Kuwabara T., Cogan D., Weis D. Retinal vascular patterns. Part V. Experimental ischaemia of the cat eye Arch. Ophthalmol. 67:1962;470-475.
433. Rintoul G.L., Raymond L.A., Baimbridge K.G. Calcium buffering and protection from excitotoxic cell death by exogenous calbindin-D28k in HEK 293 cells. Cell Calcium. 29:2001;277-287.
434. Rios L., Cluzel J., Vennat J.C., Menerath J.M., Doly M. Comparison of intraocular treatment of DMTU and SOD following retinal ischemia in rats. J. Ocul. Pharmacol. Ther. 15:1999;547-556.
435. Robbins S.G., Mixon R.N., Wilson D.J., Hart C.E., Robertson J.E., Westra I., Planck S.R., Rosenbaum J.T. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest. Ophthalmol. Vis. Sci. 35:1994;3649-3663.
436. Robison W.G. Jr. Prevention of diabetes-related retinal microangiopathy with aldose reductase inhibitors. Adv. Exp. Med. Biol. 246:1988;365-372.
437. Romano C., Price M., Bai H.Y., Olney J.W. Neuroprotectants in Honghua. glucose attenuates retinal ischemic damage Invest. Ophthalmol. Vis. Sci. 34:1993;72-80.
438. Romano C., Price M.T., Almli T., Olney J.W. Excitotoxic neurodegeneration induced by deprivation of oxygen and glucose in isolated retina. Invest. Ophthalmol. Vis. Sci. 39:1998;416-423.
439. Rosenbaum D.M., Rosenbaum P.S., Gupta A., Michaelson M.D., Hall D.H., Kessler J.A. Retinal ischemia leads to apoptosis which is ameliorated by aurintricarboxylic acid. Vision Res. 37:1997;3445-3451.
440. Rosenbaum D.M., Rosenbaum P.S., Gupta H., Singh M., Aggarwal A., Hall D.H., Roth S., Kessler J.A. The role of the p53 protein in the selective vulnerability of the inner retina to transient ischemia. Invest. Ophthalmol. Vis. Sci. 39:1998;2132-2139.
441. Rosenbaum D.M., Rosenbaum P.S., Singh M., Gupta G., Gupta H., Li B., Roth S. Functional and morphologic comparison of two methods to produce transient retinal ischemia in the rat. J. Neuroophthalmol. 21:2001;62-68.
442. Roseth S., Fykse E.M., Fonnum F. The effect of arachidonic acid and free fatty acids on vesicular uptake of glutamate and gamma-aminobutyric acid. Eur. J. Pharmacol. 341:1998;281-288.
443. Ross G.M., Shamovsky I.L., Lawrance G., Solc M., Dostaler S.M., Jimmo S.L., Weaver D.F., Riopelle R.J. Zinc alters conformation and inhibits biological activities of nerve growth factor and related neurotrophins. Nat. Med. 3:1997;872-878.
444. Rossi D.J., Oshima T., Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature. 403:2000;316-321.
445. Roth S., Osinski J.V., Park S.S., Ostwald P., Moshfeghi A.A. Measurement of purine nucleoside concentration in the intact rat retina. J. Neurosci. Methods. 68:1996;87-90.
446. Roth S., Park S.S., Sikorski C.W., Osinski J., Chan R., Loomis K. Concentrations of adenosine and its metabolites in the rat retina/choroid during reperfusion after ischemia. Curr. Eye Res. 16:1997;875-885.
447. Roth S., Li B., Rosenbaum P.S., Gupta H., Goldstein I.M., Maxwell K.M., Gidday J.M. Preconditioning provides complete protection against retinal ischemic injury in rats. Invest. Ophthalmol. Vis. Sci. 39:1998;777-785.
448. Rothman S.M., Olney J.W. Excitotoxicity and the NMDA receptor-still lethal after eight years. Trends Neurosci. 18:1995;57-58.
449. Ruppin E., Reggia J.A. Cortical spreading depression and the pathogenesis of brain disorders. a computational and neural network-based investigation Neurol. Res. 23:2001;447-456.
450. Ryu B.R., Lee Y.A., Won S.J., Noh J.H., Chang S.Y., Chung J.M., Choi J.S., Joo C.K., Yoon S.H.et al. The novel neuroprotective action of sulfasalazine through blockade of NMDA receptors. J. Pharmacol. Exp. Ther. 305:2003;48-56.
451. Sabates R., Hirose T., McMeel J.W. Electroretinography in the prognosis and classification of central retinal vein occlusion. Arch. Ophthalmol. 101:1983;232-235.
452. Safa R., Osborne N.N. Retinas from albino rats are more susceptible to ischaemic damage than age-matched pigmented animals. Brain Res. 862:2000;36-42.
453. + channel Eur. J. Pharmacol. 418:2001;89-93.
454. Sakamoto Y.R., Nakajima T.R., Fukiage C.R., Sakai O.R., Yoshida Y.R., Azuma M.R., Shearer T.R. Involvement of calpain isoforms in ischemia- reperfusion injury in rat retina. Curr. Eye Res. 21:2000;571-580.
455. Sanchez R.N., Chan C.K., Garg S., Kwong J.M., Wong M.J., Sadun A.A., Lam T.T. Interleukin-6 in retinal ischemia reperfusion injury in rats. Invest Ophthalmol Vis Sci. 44:2003;4006-4011.
456. 2 in ischemic and toxic brain injury. Neurochem. Res. 25:2000;745-753.
457. 2 as defined by gene knockouts. Biochim. Biophys. Acta. 1488:2000;139-148.
458. Sapolsky R.M. Cellular defenses against excitotoxic insults. J. Neurochem. 76:2001;1601-1611.
459. Sarantis M., Attwell D. Glutamate uptake in mammalian retinal glia is voltage- and potassium-dependent. Brain Res. 516:1990;322-325.
460. Sattler R., Tymianski M. Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol. Neurobiol. 24:2001;107-129.
461. Schmidt M., Giessl A., Laufs T., Hankeln T., Wolfrum U., Burmester T. How does the eye breathe? Evidence for neuroglobin-mediated oxygen supply in the mammalian retina. J Biol Chem. 278:2003;1932-1935.
462. 2+-ATPase inhibitor thapsigargin. Proc. Natl. Acad. Sci. USA. 88:1991;7096-7100.
463. Schurr A., Payne R.S., Miller J.J., Tseng M.T., Rigor B.M. Blockade of lactate transport exacerbates delayed neuronal damage in a rat model of cerebral ischemia. Brain Res. 895:2001;268-272.
464. Schwarcz R., Coyle J.T. Kainic acid. neurotoxic effects after intraocular injection Invest. Ophthalmol. Vis. Sci. 16:1977;141-148.
465. A neurotransmission and cerebral ischemia. J. Neurochem. 77:2001;353-371.
466. Selles-Navarro I., Villegas-Perez M., Salvador-Silva M., Ruiz-Gomez J., Vidal-Sanz M. Retinal ganglion cell death after different transient periods of pressure-induced ischemia and survival intervals. Invest. Ophthalmol. Vis. Sci. 37:1996;2002-2014.
467. Semenza G.L. Expression of hypoxia-inducible factor 1. mechanisms and consequences Biochem. Pharmacol. 59:2000;47-53.
468. Sennlaub F., Courtois Y., Goureau O. Inducible nitric oxide synthase mediates the change from retinal to vitreal neovascularization in ischemic retinopathy. J. Clin. Invest. 107:2001;717-725.
469. Seo S.Y., Yun B.S., Ryoo I.J., Choi J.S., Joo C.K., Chang S.Y., Chung J.M., Oh S., Gwag B.J.et al. Complestatin is a noncompetitive peptide antagonist of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid/kainate receptors. secure blockade of ischemic neuronal death J. Pharmacol. Exp. Ther. 299:2001;377-384.
470. Shaked I., Ben Dror I., Vardimon L. Glutamine synthetase enhances the clearance of extracellular glutamate by the neural retina. J. Neurochem. 83:2002;574-580.
471. Shay J., Ames A. Retina subjected to components of ischemia in vitro. Selective vulnerability and minimum lethal exposure of neurons and glia to oxygen and/or glucose deprivation and to loss of exchange with incubating medium. Arch. Neurol. 33:1976;715-721.
472. Sher P.K., Hu S.X. Increased glutamate uptake and glutamine synthetase activity in neuronal cell cultures surviving chronic hypoxia. Glia. 3:1990;350-357.
473. Shibuki H., Katai N., Kuroiwa S., Kurokawa T., Arai J., Matsumoto K., Nakamura T., Yoshimura N. Expression and neuroprotective effect of hepatocyte growth factor in retinal ischemia-reperfusion injury. Invest. Ophthalmol. Vis. Sci. 43:2002;528-536.
474. Shibuki H., Katai N., Yodoi J., Uchida K., Yoshimura N. Lipid peroxidation and peroxynitrite in retinal ischemia-reperfusion injury. Invest. Ophthalmol. Vis. Sci. 41:2000;3607-3614.
475. Shima D.T., Adamis A.P., Ferrara N., Yeo K.T., Yeo T.K., Allende R., Folkman J., D'Amore P.A. Hypoxic induction of endothelial cell growth factors in retinal cells. identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen Mol. Med. 1:1995;182-193.
476. Shimada N., Graf R., Rosner G., Heiss W.D. Ischemia-induced accumulation of extracellular amino acids in cerebral cortex, white matter, and cerebrospinal fluid. J. Neurochem. 60:1993;66-71.
477. Shimizu H., Graham S.H., Chang L.H., Mintorovitch J., James T.L., Faden A.I., Weinstein P.R. Relationship between extracellular neurotransmitter amino acids and energy metabolism during cerebral ischemia in rats monitored by microdialysis and in vivo magnetic resonance spectroscopy. Brain Res. 605:1993;33-42.
478. Shin D.H., Lee H.Y., Kim H.J., Lee E., Lee K.H., Lee W.J., Cho S.S., Baik S.H. In situ localization of neuronal nitric oxide synthase (nNOS) mRNA in the rat retina. Neurosci. Lett. 270:1999;53-55.
479. Shohami E., Ginis I., Hallenbeck J.M. Dual role of tumor necrosis factor alpha in brain injury. Cytokine Growth Factor Rev. 10:1999;119-130.
480. Siemkowicz E., Hansen A.J. Brain extracellular ion composition and EEG activity following 10. minutes ischemia in normo- and hyperglycemic rats Stroke. 12:1981;236-240.
481. Siesjo B.K., Katsura K., Kristian T. Acidosis-related damage. Adv. Neurol. 71:1996;209-233.
482. Siliprandi R., Canella R., Carmignoto G., Schiavo N., Zanellato A., Zanoni R., Vantini G. N-methyl-D-aspartate-induced neurotoxicity in the adult rat retina. Vis. Neurosci. 8:1992;567-573.
483. 2+] in hypoxia and ischemia in rat brain in vivo. J. Gen. Physiol. 95:1990;837-866.
484. Simon R.P., Niro M., Gwinn R. Brain acidosis induced by hypercarbic ventilation attenuates focal ischemic injury. J. Pharmacol. Exp. Ther. 267:1993;1428-1431.
485. Sims S.R. Energy metabolism and selective neuronal vulnerability following global cerebral ischemia. Neurochem. Res. 17:1992;923-931.
486. Singh M., Savitz S.I., Hoque R., Gupta G., Roth S., Rosenbaum P.S., Rosenbaum D.M. Cell-specific caspase expression by different neuronal phenotypes in transient retinal ischemia. J. Neurochem. 77:2001;466-475.
487. Smith G.G., Baird C.D. Survival time of retinal cells when deprived of their blood supply by increased intraocular pressure. Am. J. Ophthalmol. 35:1952;133-136.
488. Spertus A.D., Slakter J.S., Weissman S.S., Henkind P. Experimental carotid occlusion. funduscopic and fluorescein angiographic findings Br. J. Ophthalmol. 68:1984;47-57.
489. Spirin K.S., Saghizadeh M., Lewin S.L., Zardi L., Kenney M.C., Ljubimov A.V. Basement membrane and growth factor gene expression in normal and diabetic human retinas. Curr. Eye Res. 18:1999;490-499.
490. Stapf C., Mohr J.P. Ischemic stroke therapy. Annu. Rev. Med. 53:2002;453-475.
491. Staub F., Mackert B., Kempski O., Peters J., Baethmann A. Swelling and death of neuronal cells by lactic acid. J. Neurol. Sci. 119:1993;79-84.
492. Stefansson E., Wilson C.A., Schoen T., Kuwabara T. Experimental ischemia induces cell mitosis in the adult rat retina. Invest. Ophthalmol. Vis. Sci. 29:1988;1050-1055.
493. Steinberg G.K., Lo E.H., Kunis D.M., Grant G.A., Poljak A., DeLaPaz R. Dextromethorphan alters cerebral blood flow and protects against cerebral injury following focal ischemia. Neurosci. Lett. 133:1991;225-228.
494. Stevens W.D., Fortin T., Pappas B.A. Retinal and optic nerve degeneration after chronic carotid ligation. time course and role of light exposure Stroke. 33:2002;1107-1112.
495. Stoll G., Jander S., Schroeter M. Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system. Adv. Exp. Med. Biol. 513:2002;87-113.
496. Stone J., Maslim J., Valter Kocsi K., Mervin K., Bowers F., Chu Y., Barnett N., Provis J., Lewis G.et al. Mechanisms of photoreceptor death and survival in mammalian retina. Prog. Retin. Eye Res. 18:1999;689-735.
497. Strasser U., Lobner D., Behrens M.M., Canzoniero L.M., Choi D.W. Antagonists for group I mGluRs attenuate excitotoxic neuronal death in cortical cultures. Eur. J. Neurosci. 10:1998;2848-2855.
498. Strosznajder J., Chalimoniuk M., Strosznajder R.P., Walski M., Lupo G., Anfuso C.D., Albanese V., Alberghina M. Arachidonate transport through the blood-retina and blood-brain barrier of the rat after reperfusion of varying duration following complete cerebral ischemia. Int. J. Dev. Neurosci. 16:1998;103-113.
499. Stys P.K., Ransom B.R., Waxman S.G. Tertiary and quaternary local anesthetics protect CNS white matter from anoxic injury at concentrations that do not block excitability. J. Neurophysiol. 67:1992;236-240.
500. 2+ exchanger J. Neurosci. 12:1992;430-439.
501. Sucher N.J., Lipton S.A., Dreyer E.B. Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res. 37:1997;3483-3493.
502. Sugiyama K., Gu Z.B., Kawase C., Yamamoto T., Kitazawa Y. Optic nerve and peripapillary choroidal microvasculature of the rat eye. Invest. Ophthalmol. Vis. Sci. 40:1999;3084-3090.
503. Sun Q., Ooi V.E., Chan S.O. N-methyl-D-aspartate-induced excitotoxicity in adult rat retina is antagonized by single systemic injection of MK-801. Exp. Brain Res. 138:2001;37-45.
504. Swanson R.A., Chen J., Graham S.H. Glucose can fuel glutamate uptake in ischemic brain. J. Cereb. Blood Flow Metab. 14:1994;1-6.
505. Szabo M.E., Droy Lefaix M.T., Doly M., Carre C., Braquet P. Ischemia and reperfusion-induced histologic changes in the rat retina. Demonstration of a free radical-mediated mechanism. Invest. Ophthalmol. Vis. Sci. 32:1991;1471-1478.
506. 2+ shifts in rat retina. effects of two free radical scavengers SOD and EGB 761 Exp. Eye Res. 55:1992;39-45.
507. 2+) by free radical scavengers in the rat retina. Ophthalmic Res. 25:1993;1-9.
508. Szabo M.E., Droy Lefaix M.T., Doly M. Direct measurement of free radicals in ischemic/reperfused diabetic rat retina. Clin. Neurosci. 4:1997;240-245.
509. Szabo M.E., Haines D., Garay E., Chiavaroli C., Farine J.C., Hannaert P., Berta A., Garay R.P. Antioxidant properties of calcium dobesilate in ischemic/reperfused diabetic rat retina. Eur. J. Pharmacol. 428:2001;277-286.
510. Szatkowski M., Barbour B., Attwell D. Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature. 348:1990;443-446.
511. Takahashi K., Lam T.T., Edward D.P., Buchi E.R., Tso M.O. Protective effects of flunarizine on ischemic injury in the rat retina. Arch. Ophthalmol. 110:1992;862-870.
512. Takamatsu J., Hirano A., Levy D., Henkind P. Experimental bilateral carotid artery occlusion. a study of the optic nerve in the rat Neuropathol. Appl. Neurobiol. 10:1984;423-428.
513. Takemoto O., Tomimoto H., Yanagihara T. Induction of c-fos and c-jun gene products and heat shock protein after brief and prolonged cerebral ischemia in gerbils. Stroke. 26:1995;1639-1648.
514. Tamai K., Toumoto E., Majima A. Local hypothermia protects the retina from ischaemic injury in vitrectomy. Br. J. Ophthalmol. 81:1997;789-794.
515. Taniai M., Sato E., Mizota A., Adachi-Usami E. Protective action of nipradilol against ischemia-induced retinal damage in rats. Ophthalmic Res. 34:2002;331-337.
516. Tezel G., Wax M.B. Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J. Neurosci. 20:2000;8693-8700.
517. Thoreson W.B., Witkovsky P. Glutamate receptors and circuits in the vertebrate retina. Prog. Retin. Eye Res. 18:1999;765-810.
518. Tombaugh G.C., Sapolsky R.M. Evolving concepts about the role of acidosis in ischemic neuropathology. J. Neurochem. 61:1993;793-803.
519. Toprak A.B., Ozbilgin K., Toprak V., Tuglu I., Guler C. A histological analysis of the protective effect of ischemic preconditioning in the rat retina. Curr. Eye Res. 24:2002;234-239.
520. 2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina. Exp. Eye Res. 70:2000;475-484.
521. Touzani O., Boutin H., Chuquet J., Rothwell N. Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. J. Neuroimmunol. 100:1999;203-215.
522. Tsacopoulos M., Poitry Yamate C.L., Poitry S. Ammonium and glutamate released by neurons are signals regulating the nutritive function of a glial cell. J. Neurosci. 17:1997;2383-2390.
523. Tsacopoulos M., Poitry Yamate C.L., Poitry S., Perrottet P., Veuthey A.L. The nutritive function of glia is regulated by signals released by neurons. Glia. 21:1997;84-91.
524. Tsacopoulos M., Poitry Yamate C.L., MacLeish P.R., Poitry S. Trafficking of molecules and metabolic signals in the retina. Prog. Retin. Eye Res. 17:1998;429-442.
525. Tsujikawa A., Ogura Y., Hiroshiba N., Miyamoto K., Kiryu J., Tojo S.J., Miyasaka M., Honda Y. Retinal ischemia-reperfusion injury attenuated by blocking of adhesion molecules of vascular endothelium. Invest. Ophthalmol. Vis. Sci. 40:1999;1183-1190.
526. Tsukahara Y., Blair N.P., Eappen D.C., Moy J.J., Takahashi A., Shah G.K., Viana M.A. Ketamine suppresses ischemic injury in the rabbit retina. Invest. Ophthalmol. Vis. Sci. 33:1992;1822-1825.
527. Turnbull W. The effects of experimental retinal anaemia in rats. Trans. Can. Ophthalmol. Soc. 11:1948;116-134.
528. Uematsu D., Greenberg J.H., Reivich M., Hickey W.F. Direct evidence for calcium-induced ischemic and reperfusion injury. Ann. Neurol. 26:1989;280-283.
529. Ugarte M., Osborne N.N. The localization of endogenous zinc and the in vitro effect of exogenous zinc on the GABA immunoreactivity and formation of reactive oxygen species in the retina. Gen. Pharmacol. 30:1998;297-303.
530. Ugarte M., Osborne N.N. Zinc in the retina. Prog. Neurobiol. 64:2001;219-249.
531. Unoki K., LaVail M.M. Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor. Invest. Ophthalmol. Vis. Sci. 35:1994;907-915.
532. Vaegan, Millar T.J. Effect of kainic acid and NMDA on the pattern electroretinogram, the scotopic threshold response, the oscillatory potentials and the electroretinogram in the urethane anaesthetized cat. Vision Res. 34:1994;1111-1125.
533. Veriac S., Tissie G., Bonne C. Oxygen free radicals adversely affect the regulation of vascular tone by nitric oxide in the rabbit retina under high intraocular pressure. Exp. Eye Res. 56:1993;85-88.
534. Verkhratsky A., Shmigol A. Calcium-induced calcium release in neurones. Cell Calcium. 19:1996;1-14.
535. Verkhratsky A., Orkand R.K., Kettenmann H. Glial calcium. homeostasis and signaling function Physiol. Rev. 78:1998;99-141.
536. Vidal-Sanz M., Lafuente M.P., Mayor S., Miralles de Imperial J., Villegas-Perez M.P. Retinal ganglion cell death induced by retinal ischemia. neuroprotective effects of two alpha-2 agonists. Surv. Ophthalmol. 45(Suppl. 3):2001;S261-S267.
537. Vincent K.A., Feron O., Kelly R.A. Harnessing the response to tissue hypoxia. HIF-1 alpha and therapeutic angiogenesis Trends Cardiovasc. Med. 12:2002;362-367.
538. Vogt K., Mellor J., Tong G., Nicoll R. The actions of synaptically released zinc at hippocampal mossy fiber synapses. Neuron. 26:2000;187-196.
539. Von Graefe A. Ueber embolie der arteria centralis retinae als Urscahe plotzlicher erblingdung. Albrecht. Von Graefes Arch. Klin. Exp. Ophthalmol. 5:1859;136-157.
540. Vorwerk C.K., Hyman B.T., Miller J.W., Husain D., Zurakowski D., Huang P.L., Fishman M.C., Dreyer E.B. The role of neuronal and endothelial nitric oxide synthase in retinal excitotoxicity. Invest. Ophthalmol. Vis. Sci. 38:1997;2038-2044.
541. Vorwerk C.K., Lipton S.A., Zurakowski D., Hyman B.T., Sabel B.A., Dreyer E.B. Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine. Invest. Ophthalmol. Vis. Sci. 37:1996;1618-1624.
542. Wachtmeister L. Oscillatory potentials in the retina. what do they reveal Prog. Retin. Eye Res. 17:1998;485-521.
543. Wahl F., Obrenovitch T.P., Hardy A.M., Plotkine M., Boulu R., Symon L. Extracellular glutamate during focal cerebral ischemia in rats. time course and calcium dependency J. Neurochem. 63:1994;1003-1011.
544. Wahlestedt C., Golanov E., Yamamoto S., Yee F., Ericson H., Yoo H., Inturrisi C.E., Reis D.J. Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions. Nature. 363:1993;260-263.
545. Wakita H., Tomimoto H., Akiguchi I., Matsuo A., Lin J.X., Ihara M., McGeer P.L. Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat. Brain Res. 924:2002;63-70.
546. Wang C., Nguyen H.N., Maguire J.L., Perry D.C. Role of intracellular calcium stores in cell death from oxygen-glucose deprivation in a neuronal cell line. J. Cereb. Blood Flow Metab. 22:2002;206-214.
547. Wang C.X., Shuaib A. Involvement of inflammatory cytokines in central nervous system injury. Prog. Neurobiol. 67:2002;161-172.
548. Wang X., Niwa M., Hara A., Matsuno H., Kawase K., Kozawa O., Mow H., Uematsu T. Neuronal degradation in mouse retina after a transient ischemia and protective effect of hypothermia. Neurol. Res. 24:2002;730-735.
549. Wang X.D., Kashii S., Zhao L., Tonchev A.B., Katsuki H., Akaike A., Honda Y., Yamashita J., Yamashima T. Vitamin B6 protects primate retinal neurons from ischemic injury. Brain Res. 940:2002;36-43.
550. Wardlaw J.M., Warlow C.P., Sandercock P.A., Dennis M.S., Lindley R.I. Neuroprotection disappointment yet aGAIN. Lancet. 356:2000;597.
551. Wasilewa P., Hockwin O., Korte I. Glycogen concentration changes in retina, vitreous body and other eye tissues caused by disturbances of blood circulation. Albrecht. Von Graefes Arch. Klin. Exp. Ophthalmol. 199:1976;115-120.
552. + influx and Ca(2+)-mediated injury in myelinated CNS axons Brain Res. 644:1994;197-204.
553. Weber M., Bonaventure N., Sahel J.A. Protective role of excitatory amino acid antagonists in experimental retinal ischemia. Graefes Arch. Clin. Exp. Ophthalmol. 233:1995;360-365.
554. Wei H., Perry D.C. Dantrolene is cytoprotective in two models of neuronal cell death. J. Neurochem. 67:1996;2390-2398.
555. Weinberg D.V. Venous occlusive disease of the retina. Albert D M., Jakobiec F.A. Principles and Practice of Ophthalomology. 2000;1888-1891 W. B. Saunders, Philadelphia.
556. Weiss H. The carbohydrate reserve in the vitreous body and retina of the rabbit's eye during and after pressure ischaemia and insulin hypoglycaemia. Ophthalmol. Res. 1:1972;360-371.
557. Weiss J.H., Sensi S.L., Koh J.Y. Zn(2+). a novel ionic mediator of neural injury in brain disease Trends Pharmacol. Sci. 21:2000;395-401.
558. Wenzel H.J., Cole T.B., Born D.E., Schwartzkroin P.A., Palmiter R.D. Ultrastructural localization of zinc transporter-3 (ZnT-3) to synaptic vesicle membranes within mossy fiber boutons in the hippocampus of mouse and monkey. Proc. Natl. Acad. Sci. USA. 94:1997;12676-12681.
559. Williamson T.H. Central retinal vein occlusion. what's the story? Br. J. Ophthalmol. 81:1997;698-704.
560. Wilson C.A., Berkowitz B.A., Srebro R. Perfluorinated organic liquid as an intraocular oxygen reservoir for the ischemic retina. Invest. Ophthalmol. Vis. Sci. 36:1995;131-141.
561. Winkler B.S. The electroretinogram of the isolated rat retina. Vision Res. 12:1972;1183-1198.
562. Winkler B.S., Pourcho R.G., Starnes C., Slocum J., Slocum N. Metabolic mapping in mammalian retina. a biochemical and 3H-2-deoxyglucose autoradiographic study Exp. Eye Res. 77:2003;327-337.
563. Wise G.N. Retinal neovascularisation. Trans. Am. Ophthalmol. Soc. 54:1956;729-826.
564. Witmer A.N., Vrensen G.F., Van Noorden C.J., Schlingemann R.O. Vascular endothelial growth factors and angiogenesis in eye disease. Prog. Retin. Eye Res. 22:2003;1-29.
565. Wong F., Lantz R.C., Mauro A. The role of calcium ions in the suppression of the photoresponse during anoxia and application of metabolic inhibitors. Vision Res. 19:1979;251-254.
566. 1-adrenoceptor antagonist, protects a transient ischemic injury of the retina. Exp. Eye Res. 75:2002;591-601.
567. Wood J.P., Osborne N.N. The influence of zinc on caspase-3 and DNA breakdown in cultured human retinal pigment epithelial cells. Arch. Ophthalmol. 119:2001;81-88.
568. Wood J.P.M., Osborne N.N. Zinc and energy requirements in induction of oxidative stress to retinal pigmented epithelial cells. Neurochem. Res. 28:2003;1525-1533.
569. Wood J.P.M., DeSantis L., Chao H.M., Osborne N.N. Topically applied betaxolol attenuates ischaemia-induced effects to the rat retina and stimulates BDNF mRNA. Exp. Eye Res. 72:2001;79-86.
570. Wood J.P.M., Schmidt K.G., Melena J., Chidlow G., Osborne N.N. The beta-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants. comparison with betaxolol Exp. Eye Res. 76:2003;505-516.
571. Yamamoto F., Hiroi K., Honda Y. Effects of intravenous superoxide dismutase and catalase on electroretinogram in the cat postischemic retina. Ophthalmic Res. 26:1994;163-168.
572. Yokoyama A., Oshitari T., Negishi H., Dezawa M., Mizota A., Adachi-Usami E. Protection of retinal ganglion cells from ischemia-reperfusion injury by electrically applied Hsp27. Invest. Ophthalmol. Vis. Sci. 42:2001;3283-3286.
573. Yoneda S., Tanihara H., Kido N., Honda Y., Goto W., Hara H., Miyawaki N. Interleukin-1beta mediates ischemic injury in the rat retina. Exp. Eye Res. 73:2001;661-667.
574. Yoneda S., Tanaka E., Goto W., Ota T., Hara H. Topiramate reduces excitotoxic and ischemic injury in the rat retina. Brain Res. 967:2003;257-266.
575. Yoon Y.H., Marmor M.F. Dextromethorphan protects retina against ischemic injury in vivo. Arch. Ophthalmol. 107:1989;409-411.
576. Yotsukura J., Adachi-Usami E. Correlation of electroretinographic changes with visual prognosis in central retinal artery occlusion. Ophthalmologica. 207:1993;13-18.
577. Zeevalk G.D., Hyndman A.G. Glutamate and kainate are not directly toxic to developing amacrine cells. analysis in a Lucifer Yellow-labeled population Neurosci. Lett. 64:1986;281-286.
578. Zeevalk G.D., Hyndman A.G., Nicklas W.J. Excitatory amino acid-induced toxicity in chick retina. amino acid release, histology, and effects of chloride channel blockers J. Neurochem. 53:1989;1610-1619.
579. Zeevalk G.D., Nicklas W.J. Chemically induced hypoglycaemia and anoxia. relationship to glutamate receptor-mediated toxicity in retina J. Pharmacol. Exp. Ther. 253:1990;1285-1292.
580. Zeevalk G.D., Nicklas W.J. Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition. J. Pharmacol. Exp. Ther. 257:1991;870-878.
581. 2+ block at the N-methyl-D-aspartate receptor underlies receptor activation during inhibition of neuronal metabolism. J. Neurochem. 59:1992;1211-1220.
582. Zeevalk G.D., Bernard L.P., Sinha C., Ehrhart J., Nicklas W.J. Excitotoxicity and oxidative stress during inhibition of energy metabolism. Dev. Neurosci. 20:1998;444-453.
583. Zhang C., Takahashi K., Lam T.T., Tso M.O. Effects of basic fibroblast growth factor in retinal ischemia. Invest. Ophthalmol. Vis. Sci. 35:1994;3163-3168.
584. Zhang H., Agardh C.D., Agardh E. Increased catalase levels and hypoxanthine-enhanced nitro-blue tetrazolium staining in rat retina after ischemia followed by recirculation. Curr. Eye Res. 14:1995;47-54.
585. Zhang C., Rosenbaum D.M., Shaikh A.R., Li Q., Rosenbaum P.S., Pelham D.J., Roth S. Ischemic preconditioning attenuates apoptotic cell death in the rat retina. Invest. Ophthalmol. Vis. Sci. 43:2002;3059-3066.
586. Zhang X., Chaudhry A., Chintala S.K. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage. Mol. Vis. 9:2003;238-248.
587. Zheng Z., Lee J.E., Yenari M.A. Stroke. molecular mechanisms and potential targets for treatment Curr. Mol. Med. 3:2003;361-372.
588. Zhou Y., Lindner L.E., Chiou G.C., Morgan K.P., Li Z. Transient retinal ischemia-reperfusion in rats. Chin. Med. J. 113:2000;461-465.
589. Zhou Z.J., Fain G.L. Neurotransmitter receptors of starburst amacrine cells in rabbit retinal slices. J. Neurosci. 15:1995;5334-5345.
590. Zhu Y., Ohlemiller K.K., McMahan B.K., Gidday J.M. Mouse models of retinal ischemic tolerance. Invest. Ophthalmol. Vis. Sci. 43:2002;1903-1911.
591. Zini S., Roisin M.P., Armengaud C., Ben Ari Y. Effect of potassium channel modulators on the release of glutamate induced by ischaemic-like conditions in rat hippocampal slices. Neurosci. Lett. 153:1993;202-205.
592. Zipfel G.J., Babcock D.J., Lee J.M., Choi D.W. Neuronal apoptosis after CNS injury. the roles of glutamate and calcium J. Neurotrauma. 17:2000;857-869.